







 HSKA - Stock quote for Heska Corp - MSN Money















msn  back to msn home

money










web search














Sign in








Change language & content:

América Latina (español)
Argentina (español)
Australia (English)
België (Nederlands)
Belgique (français)
Brasil (português)
Canada (English)
Canada (français)
Chile (español)
Colombia (español)
Danmark (Dansk)
Deutschland (Deutsch)
España (español)
France (français)
India (English)
Indonesia (Bahasa Indonesia)
Ireland (English)
Italia (italiano)
Malaysia (English)
México (español)
Nederland (Nederlands)
New Zealand (English)
Norge (norsk, bokmål)
Österreich (Deutsch)
Perú (español)
Philippines (English)
Polska (polski)
Portugal (Português)
Schweiz (Deutsch)
Singapore (English)
South Africa (English)
Suisse (français)
Suomi (suomi)
Sverige (svenska)
Türkiye (Türkçe)
United Arab Emirates (English)
United Kingdom (English)
United States (English)
United States (español)
Venezuela (español)
Việt Nam (Tiếng Việt)
Ελλάδα (ελληνικά)
Россия (Pусский)
ישראל (עברית)‏
الإمارات العربية المتحدة (العربية‏)
المملكة العربية السعودية (العربية‏)
مصر (العربية‏)
ไทย (ไทย)
한국 (한국어)
中华人民共和国 (简体中文)
台灣 (繁體中文)
日本 (日本語)
香港特别行政區 (繁體中文)



Switch to Latino (Español)



 Feedback



Help






























AdChoices














Heska Corp
NASDAQ: HSKA



US Markets Open In41 min










AdChoices








100.17


▼


-1.24
-1.22%



After Hours : 
-
-
-



 July 21, 2017 4:22 PM EDT. Delayed 15 minutes; NASDAQ. Currency In USD                
















Save














            Summary
        



            Financials
        



            Analysis
        



            Options
        



            Ownership
        



            Company
        



            History
        



            Related
        


















































Open
102.52


Previous Close
101.41


Volume (Avg) 
42.47k (85.59k)


Day's Range
99.99-102.75


52Wk Range
41.23-110.25


Market Cap.
712.81M


Dividend Rate (Yield)
0.40 (-%)


Beta
0.81


Shares Outstanding
7.12M


P/E Ratio (EPS)
53.48 (1.87) 









Recent News







Heska (HSKA) –

                            
                            StreetInsider
                        
7/11/2017





 
Veterinary Laboratory Testing Services Market 2017 Outlook Trends, Growth Factors, Top Manufacturers, Research Methodology and Forecasts by 2021

                            
                            Green Mountain Outlook
                        
1 hr ago





 
Europe Veterinary Diagnostics Market predicted to reach to reach to a value of $1.716 billion by 2021

                            
                            Medgadget
                        
1 day ago





 
Veterinary Diagnostics Market – Market Trends and analysis 2016-2021

                            
                            Medgadget
                        
1 day ago





 
Analysts See $0.37 EPS for Heska (HSKA), Oconee Federal Financial (OFED) Sentiment Is 0.33

                            
                            the Bibey Post
                        
2 days ago






Veterinary Chemistry Analyzer Market by Product Application & Animal - Global Forecast to 2022

                            
                            The Business Journal
                        
3 days ago







 
Heska to Present at Canaccord Genuity 37th Annual Growth Conference on August 10

                            
                            Med India
                        
3 days ago






Veterinary Antiinfectives Global Market, By Geography, Growth, Data Mining and Forecasts 2022

                            
                            emailwire.com
                        
3 days ago






Vanguard Group Inc. Has $167.98 Million Stake in Matador Resources Company (MTDR)

                            
                            nolopodrasdejardever.com
                        
3 days ago






The Matador Resources Company (NYSE:MTDR) Shares Sold by Cwm LLC

                            
                            techzolix.com
                        
3 days ago






Learn details of the global veterinary vaccines market

                            
                            Whatech
                        
3 days ago






Companion Animal Vaccines Market Revenue and Share by Manufacturers forecast to 2022

                            
                            Trade Calls
                        
4 days ago








1,995 Shares in Heska Corporation (HSKA) Acquired by Invictus RG

                            
                            themarketsdaily.com
                        
5 days ago






Analysts See $0.35 EPS for Heska Corp (HSKA)

                            
                            presstelegraph.com
                        
5 days ago






Veterinary Vaccines Market by Type - Livestock Vaccines and Companion Vaccines

                            
                            emailwire.com
                        
5 days ago






Royce & Associates LP Lowers Stake in Heska Corporation (NASDAQ:HSKA)

                            
                            Breeze
                        
6 days ago






$2.01 Billion Veterinary Immunodiagnostics Market 2017 - Global Opportunity Analysis and Industry Forecasts to 2022 - Research and Markets

                            
                            TMCnet.com
                        
6 days ago






Nicholas Investment Partners LP Purchases Shares of 21,791 Heska Corporation (HSKA)

                            
                            BNS
                        
7/16/2017























AdChoices
















AdChoices

















AdChoices




















Markets











DOW

DOW



▼

21,580.07


-31.71
-0.15%













Last updated time
7/24/2017 8:48 AM EDT







Markets





NASDAQ

NASDAQ



▼

6,387.75




-2.25
-0.04%










FTSE 100

FTSE 100



▼

7,388.11




-64.80
-0.87%










NYSE Composite

NYSE Composite



▼

11,924.60




-19.90
-0.17%



















AdChoices
















                Feedback
            







Send Feedback
Provide Feedback
Report a Problem


We appreciate your input!



Select a category:

I'm having problems with Top Destinations
I'm having issues searching
I'm having problems with Featured Apps
I see an error in the content
Other



How we can improve?





Please give an overall site rating:









Submit
Close


Privacy Statement


Help


Help & Support



 











 




	Heska - Accurate and reliable veterinary, point-of-care diagnostic products and systems for veterinarian clinics worldwide.




























heska



Search for:





 Log in





Home
Blood Diagnostics


Diagnostic Solutions
Reset Program

Overview
Testimonials

Chemistry

Element DC
DRI-CHEM 4000
DRI-CHEM 7000

Hematology

HemaTrue
Element HT5

Blood Gas & Electrolyte


Element POC


Immunoassay


Element i   NEW


Heartworm Tests


Solo Step Heartworm




Other

Infusion Pump
Supplements
Lab Software




Services

Education
Partner Advantage




Digital Imaging


HD Digital X-ray
Small Animal

CloudDR



Equine

Uno 6
Slate 6
Slate 3 +
		 



Digital Ultrasound

MyLab Gamma
MyLab Six
MyLab Delta    NEW
MyLab Alpha
MyLab Class C
MyLab Seven
MyLab Five
MyLab 30
MyLab 40
Tranducers




Allergy



Allergy Testing & Treatment
Dx Lab Services




Company


Company

About Us
Contact Heska
Heska Testimonials
Cuattro Testimonials
Driving Directions
Heska Worldwide
Heska Manufacturing
Patent Portfolio
Publications
 

Careers

Working at Heska
Search Careers
		 

News/Events

Heska/Cuattro Press Releases



Investors

Investor Relations
Archived Presentations
Corporate Governance
Management




Support



Heska Support
Cuattro Support
Product SDS




Contact





































NEWS & EVENTS

Online Bill Pay Now Available!

RESET! Lab Analyzer, Warranty & Service

TSH Now Available In-Clinic.
Plus NEW Bile Acids!

 
















Diagnostics/Treatment


Digital Imaging


Allergy Testing & Treatment


Customer Support


Company


Privacy Policy


Terms and Conditions


Conditions of Sale/Rental







Sign up for our Email Newsletter







For Email Marketing you can trust





 


Our site uses cookies to improve your customer experience. More Information















	Heska - Offers diagnostic and laboratory testing systems, as well as other small animal products to help veterinarians focus on the health care for their clients and pets.




























heska


Search for:





 Log in







Home
Blood Diagnostics


Diagnostic Solutions
Reset Program

Overview
Testimonials

Chemistry

Element DC
DRI-CHEM 4000
DRI-CHEM 7000

Hematology

HemaTrue
Element HT5

Blood Gas & Electrolyte


Element POC


Immunoassay


Element i   NEW


Heartworm Tests


Solo Step Heartworm




Other

Infusion Pump
Supplements
Lab Software




Services

Education
Partner Advantage




Digital Imaging


HD Digital X-ray
Small Animal

CloudDR



Equine

Uno 6
Slate 6
Slate 3 +
		 



Digital Ultrasound

MyLab Gamma
MyLab Six
MyLab Delta    NEW
MyLab Alpha
MyLab Class C
MyLab Seven
MyLab Five
MyLab 30
MyLab 40
Tranducers




Allergy



Allergy Testing & Treatment
Dx Lab Services




Company


Company

About Us
Contact Heska
Heska Testimonials
Cuattro Testimonials
Driving Directions
Heska Worldwide
Heska Manufacturing
Patent Portfolio
Publications
 

Careers

Working at Heska
Search Careers
		 

News/Events

Heska/Cuattro Press Releases



Investors

Investor Relations
Archived Presentations
Corporate Governance
Management




Support



Heska Support
Cuattro Support
Product SDS




Contact





Diagnostics/ Treatment



Reset


Lab Systems


Heartworm


IV Pumps


Supplements




	Heska’s line of product advancements include state-of-the-art chemistry, hematology, and blood gas & electrolyte systems, as well as single-step heartworm, early renal healthscreens, allergy testing and allergy treatment. 



















				 











				 












Diagnostics/Treatment


Digital Imaging


Allergy Testing & Treatment


Customer Support


Company


Privacy Policy


Terms and Conditions


Conditions of Sale/Rental







Sign up for our Email Newsletter







For Email Marketing you can trust








Our site uses cookies to improve your customer experience. More Information



















    HSKA Key Statistics - Heska Corp. Financial Ratios - MarketWatch




































Bulletin






Investor Alert







New York Markets Open in:



Market Snapshot
Analyst Ratings


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Heska Corp.

                  NASDAQ: HSKA
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Heska Corp.



After Hours
 --Quotes are delayed by 20 min
Jul 21, 2017, 4:22 p.m.


HSKA

/quotes/zigman/2380047/composite


$
100.17




Change

0.00
0.00%

Volume
Volume 545
Quotes are delayed by 20 min








/quotes/zigman/2380047/composite
Previous close

$
			101.41
		


$
				100.17
			
Change

-1.24
-1.22%





Day low
Day high
$99.99
$102.75










52 week low
52 week high

            $41.23
        

            $110.25
        

















			Company Description 


			Heska Corp. engages in the research, development and manufacture of veterinary products. The company operates through two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals & Products. The Core Companion Animal Health segment supplies blood testing instruments, digital imagin...
		


                Heska Corp. engages in the research, development and manufacture of veterinary products. The company operates through two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals & Products. The Core Companion Animal Health segment supplies blood testing instruments, digital imaging software, heartworm diagnostic tests and preventive products, allergy immunotherapy products, and allergy testing. The Other Vaccines, Pharmaceuticals and Products segment develops and distributes vaccines and pharmaceutical products. Its solutions include, dri-chem 4000, 7000, hematrue, element ht5, element i and solo step heartworm. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.
            




Valuation

P/E Current
70.05


P/E Ratio (with extraordinary items)
54.61


P/E Ratio (without extraordinary items)
50.07


Price to Sales Ratio
4.05


Price to Book Ratio
5.78


Price to Cash Flow Ratio
90.02


Enterprise Value to EBITDA
33.18


Enterprise Value to Sales
5.27


Total Debt to Enterprise Value
0.00

Efficiency

Revenue/Employee
397,807.00


Income Per Employee
32,135.00


Receivables Turnover
6.96


Total Asset Turnover
1.08

Liquidity

Current Ratio
1.71


Quick Ratio
1.08


Cash Ratio
0.33



Profitability

Gross Margin
41.43


Operating Margin
12.71


Pretax Margin
12.69


Net Margin
8.08


Return on Assets
8.74


Return on Equity
13.96


Return on Total Capital
13.86


Return on Invested Capital
13.96

Capital Structure

Total Debt to Total Equity
0.86


Total Debt to Total Capital
0.85


Total Debt to Total Assets
0.57





      Officers and Executives
    



Name
Age
Officer Since
Title





Mr. Kevin S. Wilson 
41
2013
President, Chief Executive Officer & Director



Mr. Jason A. Napolitano 
47
2002
Secretary, Chief Operating & Strategist Officer



Mr. John  McMahon 
51
2015
Chief Financial Officer & Vice President



Dr. Nancy  Wisnewski 
53
1993
EVP-Diagnostic Operations & Product Development



Dr. Michael J. McGinley 
55
1997
President-Biologicals & Pharmaceuticals





Insider Actions


 – Purchase

 – Sale
1
 – Number of Transactions











{"OrganizationDocuments":[{"Documents":[{"document":[{"reportDateGroup":[{"reportDate":"2011-06-09","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-05-17","tradeTypeGroup":[{"numTransactions":"3","tradeType":"D"},{"numTransactions":"1","tradeType":"A"}]},{"reportDate":"2011-05-16","tradeTypeGroup":[{"numTransactions":"2","tradeType":"D"},{"numTransactions":"8","tradeType":"A"}]},{"reportDate":"2011-05-13","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-12","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-11","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-02","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-03-10","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-02-17","tradeTypeGroup":[{"numTransactions":"4","tradeType":"D"},{"numTransactions":"2","tradeType":"A"}]},{"reportDate":"2011-02-15","tradeTypeGroup":[{"numTransactions":"8","tradeType":"A"},{"numTransactions":"1","tradeType":"D"}]}]}]}]}]}


Date
Name
Shares
Transaction
Value





06/12/2017

Scott Humphrey 
Director

567


 
Award at $0 per share.


0


06/01/2017

Steven M. Asakowicz 
EVP, Comp. Animal Health Sales

100


 
Disposition at $100.15 per share.


10,015


06/01/2017

Steven M. Asakowicz 
EVP, Comp. Animal Health Sales

100


 
Disposition at $100.13 per share.


10,013


06/01/2017

Steven M. Asakowicz 
EVP, Comp. Animal Health Sales

1


 
Disposition at $100.06 per share.


100


06/01/2017

Steven M. Asakowicz 
EVP, Comp. Animal Health Sales

76


 
Disposition at $100.04 per share.


7,603


06/01/2017

Steven M. Asakowicz 
EVP, Comp. Animal Health Sales

1


 
Disposition at $100 per share.


100


06/01/2017

Steven M. Asakowicz 
EVP, Comp. Animal Health Sales

104


 
Disposition at $100 per share.


10,400


06/01/2017

Steven M. Asakowicz 
EVP, Comp. Animal Health Sales

382


 
Derivative/Non-derivative trans. at $18.13 per share.


6,925


05/31/2017

Michael J. McGinley 
Presi, Biologic. & Pharm.

5,130


 
Disposition at $98.53 per share.


505,458


05/31/2017

Michael J. McGinley 
Presi, Biologic. & Pharm.

6,059


 
Disposition at $98.53 per share.


596,993


05/31/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

950


 
Disposition at $98 per share.


93,100


05/31/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

2,895


 
Disposition at $98 per share.


283,710


05/31/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

626


 
Disposition at $98 per share.


61,348


05/31/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

950


 
Derivative/Non-derivative trans. at $72.85 per share.


69,207


05/31/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

2,895


 
Derivative/Non-derivative trans. at $39.76 per share.


115,105


05/31/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

626


 
Derivative/Non-derivative trans. at $39.76 per share.


24,889


05/26/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

100


 
Disposition at $98.07 per share.


9,807


05/26/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

45


 
Disposition at $98.04 per share.


4,411


05/26/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

355


 
Disposition at $98.04 per share.


34,804


05/26/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

2,814


 
Disposition at $98 per share.


275,772


05/26/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

1,964


 
Disposition at $98 per share.


192,472


05/26/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

1,478


 
Disposition at $98 per share.


144,844


05/26/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

100


 
Derivative/Non-derivative trans. at $39.76 per share.


3,976


05/26/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

45


 
Derivative/Non-derivative trans. at $39.76 per share.


1,789


05/26/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

355


 
Derivative/Non-derivative trans. at $18.13 per share.


6,436


05/26/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

2,814


 
Derivative/Non-derivative trans. at $18.13 per share.


51,017


05/26/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

1,964


 
Derivative/Non-derivative trans. at $7.36 per share.


14,455


05/26/2017

Rodney A. Lippincott 
EVP, Comp. Animal Health Sales

1,478


 
Derivative/Non-derivative trans. at $8.35 per share.


12,341


05/24/2017

Nancy Wisnewski 
EVP, Diag. Ops & Prod. Dev.

250


 
Disposition at $100.17 per share.


25,042


05/24/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

5,000


 
Disposition at $100.5 per share.


502,500


05/23/2017

Carol A. Wrenn 
Director

200


 
Disposition at $97.02 per share.


19,404


05/23/2017

Carol A. Wrenn 
Director

100


 
Disposition at $97 per share.


9,700


05/23/2017

Carol A. Wrenn 
Director

100


 
Disposition at $96.95 per share.


9,695


05/23/2017

Carol A. Wrenn 
Director

300


 
Disposition at $96.93 per share.


29,079


05/23/2017

Carol A. Wrenn 
Director

930


 
Disposition at $96.93 per share.


90,144


05/23/2017

John McMahon 
VP, Chief Financial Officer

170


 
Disposition at $96.93 per share.


16,478


05/23/2017

John McMahon 
VP, Chief Financial Officer

292


 
Disposition at $97.03 per share.


28,332


05/23/2017

John McMahon 
VP, Chief Financial Officer

125


 
Disposition at $97.03 per share.


12,128


05/23/2017

Carol A. Wrenn 
Director

1,630


 
Derivative/Non-derivative trans. at $8.1 per share.


13,203


05/23/2017

John McMahon 
VP, Chief Financial Officer

292


 
Derivative/Non-derivative trans. at $39.76 per share.


11,609


05/23/2017

John McMahon 
VP, Chief Financial Officer

125


 
Derivative/Non-derivative trans. at $28.39 per share.


3,548


05/04/2017

Sharon L. Riley 
Director

1,000


 
Acquisition at $90 per share.


90,000


05/01/2017

G. Irwin Gordon 
Director

544


 
Award at $0 per share.


0


05/01/2017

David E. Sveen 
Director

544


 
Award at $0 per share.


0


05/01/2017

Carol A. Wrenn 
Director

544


 
Award at $0 per share.


0


05/01/2017

Sharon L. Riley 
Director

544


 
Award at $0 per share.


0


05/01/2017

Bonnie J. Trowbridge 
Director

544


 
Award at $0 per share.


0


05/01/2017

G. Irwin Gordon 
Director

5,000


 
Derivative/Non-derivative trans. at $15.8 per share.


79,000


05/01/2017

G. Irwin Gordon 
Director

4,016


 
Derivative/Non-derivative trans. at $22.5 per share.


90,360


05/01/2017

G. Irwin Gordon 
Director

5,000


 
Derivative/Non-derivative trans. at $6.66 per share.


33,300


05/01/2017

G. Irwin Gordon 
Director

5,000


 
Derivative/Non-derivative trans. at $8.6 per share.


43,000


05/01/2017

G. Irwin Gordon 
Director

716


 
Derivative/Non-derivative trans. at $110.24 per share.


78,931


05/01/2017

G. Irwin Gordon 
Director

819


 
Derivative/Non-derivative trans. at $110.24 per share.


90,286


04/11/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

200


 
Disposition at $100.73 per share.


20,146


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.96 per share.


10,396


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.59 per share.


10,359


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.55 per share.


10,355


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.45 per share.


10,345


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.4 per share.


10,340


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.38 per share.


10,338


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.38 per share.


10,338


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.33 per share.


10,333


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.32 per share.


10,332


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.32 per share.


10,332


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

300


 
Disposition at $103.31 per share.


30,993


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.26 per share.


10,326


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.26 per share.


10,326


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

400


 
Disposition at $103.25 per share.


41,300


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

200


 
Disposition at $103.24 per share.


20,648


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.23 per share.


10,323


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.2 per share.


10,320


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.19 per share.


10,319


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.13 per share.


10,313


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

200


 
Disposition at $103.11 per share.


20,622


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $103.03 per share.


10,303


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

30


 
Disposition at $102.94 per share.


3,088


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

200


 
Disposition at $102.93 per share.


20,586


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

90


 
Disposition at $102.92 per share.


9,262


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $102.9 per share.


10,290


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $102.88 per share.


10,288


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $102.87 per share.


10,287


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

110


 
Disposition at $102.85 per share.


11,313


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

300


 
Disposition at $102.84 per share.


30,852


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $102.83 per share.


10,283


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $102.76 per share.


10,276


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $102.75 per share.


10,275


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $102.71 per share.


10,271


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $102.65 per share.


10,265


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $102.57 per share.


10,257


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

170


 
Disposition at $102.56 per share.


17,435


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $102.53 per share.


10,253


04/10/2017

Jason A. Napolitano 
COO, Chief Strategist and Sec.

100


 
Disposition at $100.75 per share.


10,075








/news/latest/company/us/hska

      MarketWatch News on HSKA
    




 The top-performing stocks from each region around the world
8:06 p.m. Feb. 16, 2017
 - Shawn Langlois




 Heska downgraded to neutral from buy at B. Riley
8:10 a.m. Sept. 22, 2016
 - Tomi Kilgore




 Heska downgraded to neutral from buy at B. Riley
10:09 a.m. Sept. 21, 2016
 - Tomi Kilgore




 Stocks to watch Friday: Goldman, Bally, Scotts
6:53 a.m. Aug. 10, 2012
 - MarketWatch









/news/nonmarketwatch/company/us/hska

      Other News on HSKA
    





Why Heska (HSKA) Could Be Positioned for a Surge

8:46 a.m. June 2, 2017
 - Zacks.com




 10-Q: HESKA CORP
6:05 a.m. May 5, 2017
 - Edgar Online -  (EDG = 10Q, 10K)





5 Top Efficient Stocks to Boost Your Portfolio

7:59 a.m. May 4, 2017
 - Zacks.com





Exelixis (EXEL) Posts Earnings in Q1, Cabometyx in Focus

4:09 p.m. May 2, 2017
 - Zacks.com





Heska's (HSKA) CEO Kevin Wilson on Q1 2017 Results - Earnings Call Transcript

4:03 p.m. May 2, 2017
 - Seeking Alpha





Radius Health (RDUS) Posts Wider Q1 Loss, Tymlos Approved 

3:39 p.m. May 2, 2017
 - Zacks.com





Here's Why Heska Corporation Is Dropping Today

12:33 p.m. May 2, 2017
 - Motley Fool





CVS Health (CVS) Q1 Earnings Beat Estimates, Decrease Y/Y

10:41 a.m. May 2, 2017
 - Zacks.com





Notable earnings before Tuesday’s open

5:30 p.m. May 1, 2017
 - Seeking Alpha





Hill-Rom (HRC) Beats Earnings & Revenue Estimates in Q2

9:59 a.m. May 1, 2017
 - Zacks.com





Sarepta (SRPT) Q1 Loss Narrows, Exondys 51 Sales Pick Up

10:43 a.m. April 28, 2017
 - Zacks.com





AstraZeneca (AZN) Q1 Earnings Beat, Revenues Meet Estimates

10:31 a.m. April 28, 2017
 - Zacks.com





Acorda (ACOR) Q1 Loss Wider Than Expected, Revenues Miss 

10:29 a.m. April 28, 2017
 - Zacks.com





Seattle Genetics (SGEN) Q1 Loss Widens, Sales Top Estimates

9:57 a.m. April 28, 2017
 - Zacks.com





Align Technology (ALGN) Beats on Q1 Earnings and Revenues

9:31 a.m. April 28, 2017
 - Zacks.com





AbbVie (ABBV) Q1 Earnings Beat Estimates, Revenues Up Y/Y

4:52 p.m. April 27, 2017
 - Zacks.com





Bayer (BAYRY) Beats Q1 Earnings, Revenue Estimates 

2:59 p.m. April 27, 2017
 - Zacks.com





Alexion (ALXN) Tops Q1 Earnings, Revenues; Ups '17 View

2:42 p.m. April 27, 2017
 - Zacks.com





The Medicines Company (MDCO) Q1 Loss Wider Than Expected

9:52 a.m. April 27, 2017
 - Zacks.com





Chemed's (CHE) Earnings and Revenues Beat Estimates in Q1

9:03 a.m. April 27, 2017
 - Zacks.com


Loading more headlines...












At a Glance

Heska Corp.
3760 Rocky Mountain Avenue


Loveland, Colorado 80538




Phone
1 9704937272


Industry
Pharmaceuticals


Sector
Health Care/Life Sciences


Fiscal Year-end
12/2017


View SEC Filings




Revenue
$130.08M


Net Income
$10.51M


2016 Sales Growth 
24.4%


Employees

        327.00


Annual Report for HSKA











/news/pressrelease/company/us/hska

      Press Releases on HSKA
    




 Heska to Present at Canaccord Genuity 37th Annual Growth Conference on August 10
4:05 p.m. July 20, 2017
 - PR Newswire - PRF




 Heska Schedules Second Quarter 2017 Financial Results Conference Call for July 31, 2017
8:00 a.m. July 11, 2017
 - PR Newswire - PRF




 Scott Humphrey Joins Heska's Board of Directors
9:00 a.m. June 13, 2017
 - PR Newswire - PRF




 Investor Network: Heska Corporation to Host Earnings Call
8:05 a.m. May 2, 2017
 - ACCESSWIRE




 Heska Reports First Quarter Results
8:00 a.m. May 2, 2017
 - PR Newswire - PRF




 Heska To Present at Four Upcoming Conferences
8:00 a.m. April 27, 2017
 - PR Newswire - PRF




 Reminder: Heska Annual Meeting of Stockholders on May 1, 2017
5:20 p.m. April 25, 2017
 - PR Newswire - PRF




 Heska Schedules First Quarter 2017 Financial Results Conference Call for May 2, 2017
8:00 a.m. April 13, 2017
 - PR Newswire - PRF




 Heska Schedules Annual Meeting of Stockholders for May 1, 2017
8:00 a.m. April 12, 2017
 - PR Newswire - PRF




 Gartner Set to Join S&P 500; Dun & Bradstreet, Wintrust Financial and INC Research to Join S&P MidCap 400; Heska to Join S&P SmallCap 600
6:21 p.m. March 29, 2017
 - PR Newswire - PRF




 Post Earnings Coverage as VWR Corp. Q4 2016 Results Outperformed Projections
8:22 a.m. March 14, 2017
 - ACCESSWIRE




 Heska Reports Record Quarter and Annual Results
9:00 a.m. Feb. 28, 2017
 - PR Newswire - PRF




 Heska Schedules Fourth Quarter and Year-End 2016 Financial Results Conference Call for February 28, 2017
5:27 p.m. Jan. 31, 2017
 - PR Newswire - PRF




 Heska to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum on November 17
8:00 a.m. Nov. 3, 2016
 - PR Newswire - PRF




 Heska Reports Record Third Quarter Results
8:00 a.m. Nov. 1, 2016
 - PR Newswire - PRF




 Heska Schedules Third Quarter 2016 Earnings Release and Conference Call for November 1, 2016
8:00 a.m. Oct. 19, 2016
 - PR Newswire - PRF




 Heska Announces Executive Promotions to Further Growth Initiatives
5:35 p.m. Sept. 29, 2016
 - PR Newswire - PRF




 Heska to Present at CL King's 14th Annual Best Ideas Conference 2016 on September 13
9:00 a.m. Sept. 6, 2016
 - PR Newswire - PRF




 Heska to Present at CL King's 14th Annual Best Ideas Conference 2016 on September 13
9:00 a.m. Sept. 6, 2016
 - PR Newswire - PRF




 Heska to Present at Canaccord Genuity 36th Annual Growth Conference on August 10, 2016
12:00 p.m. Aug. 4, 2016
 - PR Newswire - PRF


Loading more headlines...
















Log In




8:48 AM EDT
July 24, 2017


/marketstate/country/us
New York

	Pre


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
8:48aDollar edges higher ahead of Fed meeting, but remains sharply lower for July
8:47aCharges dropped after ‘London Whale’ accused Jamie Dimon of making him a fall guy
8:46aGold tries to run up streak of gains to 7 sessions
8:46aAmerican workers are slaves to their emails — these digital organizers aim to help
8:45aU.S. stocks search for direction as busy earnings week gets under way
8:44aThis app will analyze your DNA to help you lose weight
8:43aJ.C. Penney accepting Apple Pay nationwide
8:43aPandora Media shares gain more than 4% premarket after upbeat analyst note
8:40aArconic shares surge 6% premarket after company beats on profit, raises outlook
8:38aRepublican health bill still mystery before vote | Trump averaged 50% or higher approval in 17 states   
8:37aArconic to no longer sell the Reynobond PE product used in high-rise construction
8:35aArconic's stock soars 4.9% premarket after Q2 results
8:34aArconic raises 2017 revenue outlook to $12.3 bln-$12.7 bln from $11.8 bln-$12.4 bln
8:34aArconic raises 2017 adj. EPS outlook to $1.15-$1.20 from $1.10-$1.20
8:33aArconic Q2 revenue $3.26 bln vs. $3.23 bln a year ago; FactSet consensus $3.20 bln
8:33aArconic Q2 adj. EPS 32 cents; FactSet consensus 26 cents
8:32aArconic Q2 EPS 43 cents vs. 27 cents a year ago
8:31aPussy Riot is raising $80,000 so everyone can experience Russian prisons
8:24aVice Media lays off 2% of staff as focus turns more toward video
8:24aSchlumberger stock price target cut to $93 from $107 at FBR & Co.
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,580.07

-31.71
-0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,387.75

-2.25
-0.04%





s&p 500

/quotes/zigman/3870025/realtime
2,472.54

-0.91
-0.04%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































HSKA Stock Price - Heska Corp. Stock Quote (U.S.: Nasdaq) - MarketWatch



























 














































 















Sections

Watchlist




























Signup
 • 
Login

Search







Bulletin











US
Europe
Asia
FX
Rates
Futures


Range


1D
5D
1M
3M
6M
1Y
2Y











DJIA F

21,514


-4


-0.02%











S&P F

2,469.00


-0.50


-0.02%











NASDAQ F

5,921.00


2.25


0.04%











Gold

1,264.30


3.30


0.26%











Silver

16.565


0.108


0.66%











Crude Oil

45.97


0.20


0.44%

















S&P 500 Movers(%)



CTAS 
9.2




COF 
8.6




ETFC 
5.1




SYF 
4.5






HP
-5.5




ISRG
-4.6




HBAN
-4.4




CHK
-3.1














Latest NewsAll Times Eastern








8:47a

Updated
Dollar edges higher ahead of Fed meeting, but remains sharply lower for July



8:46a

Updated
Charges dropped after ‘London Whale’ accused Jamie Dimon of making him a fall guy



8:46a

Updated
Gold tries to run up streak of gains to 7 sessions



8:45a

Updated
American workers are slaves to their emails — these digital organizers aim to help



8:45a

Updated
U.S. stocks search for direction as busy earnings week gets under way



8:43a

Updated
This app will analyze your DNA to help you lose weight



8:43a

J.C. Penney accepting Apple Pay nationwide



8:42a

Pandora Media shares gain more than 4% premarket after upbeat analyst note



8:39a

Arconic shares surge 6% premarket after company beats on profit, raises outlook



8:38a

Republican health bill still mystery before vote | Trump averaged 50% or higher approval in 17 states   












to be replaced

























































































































    




Home


Investing


Quotes


Stocks


United States


HSKA


Overview



Compare Quotes
Stock Screener
Earnings Calendar
Sectors
Nasdaq

 



HSKA
U.S.: Nasdaq


Join TD Ameritrade

Find a Broker


Heska Corp.

Watchlist 
CreateHSKAAlert



  


After Hours

Last Updated: Jul 21, 2017 4:22 p.m. EDT
Delayed quote



$
100.17



0.00
0.00%



After Hours Volume:
545





Close
Chg
Chg %




$100.17
-1.24
-1.22%





  









Advanced Charting


1D
5D
1M
3M
6M
YTD
1Y
3Y
All




$
%
Vol


Advanced Charting

  




49.22% vs Avg.




                Volume:               
                
                    41.9K
                


                65 Day Avg. - 85.2K
            





Open: 102.52
Close: 100.17



99.9900
Day Low/High
102.7500





Day Range



41.2300
52 Week Low/High
110.2500


   








Your Watchlist



Customize MarketWatch
Have Watchlists? Log in to see them here or sign up to get started.

Create Account

                    … or Log In

















Symbol
Last
Chg
Chg %

















No Items in Watchlist
There are currently no items in this Watchlist.

Add Ticker to Watchlist




 (Go to Your Watchlist) 




No Saved Watchlists
Create a list of the investments you want to track.

Create Watchlist

                    …or try this starter list






Uh oh
Something went wrong while loading Watchlist.

Go to Watchlist



 

Recently Viewed Tickers



No Recent Tickers
Visit a quote page and your recently viewed tickers will be displayed here.

Search Tickers



















   





Overview


Profile


News


Charts


Financials


Historical Quotes


Analyst Estimates


Options


SEC Filings


Insiders



   




Key Data



Open
$102.52



Day Range
99.9900 - 102.7500



52 Week Range
41.2300 - 110.2500



Market Cap
$712.81M



Shares Outstanding
7.12M



Public Float
6.42M



Beta
0.60



Rev. per Employee
$407.7K



P/E Ratio
53.57



EPS
$1.87



Yield
n/a



Dividend
$0.10



Ex-Dividend Date
Sep 26, 2012



Short Interest
236.21K
06/30/17


% of Float Shorted
3.68%



Average Volume
85.19K




 


Performance




5 Day


-0.61%







1 Month


2.74%







3 Month


-4.75%







YTD


39.90%







1 Year


136.47%









  

 
 


Recent News



MarketWatch
Other Dow Jones











The top-performing stocks from each region around the world

Feb. 19, 2017 at 7:43 p.m. ET
by Shawn Langlois









Heska downgraded to neutral from buy at B. Riley


Sep. 22, 2016 at 8:11 a.m. ET
by Tomi Kilgore









Heska downgraded to neutral from buy at B. Riley


Sep. 21, 2016 at 10:09 a.m. ET
by Tomi Kilgore










Stocks to watch Friday: Goldman, Bally, Scotts

Aug. 10, 2012 at 6:54 a.m. ET
by MarketWatch














Stocks to Watch: Jabil, Kraft, Biogen

Sep. 26, 2012 at 9:08 a.m. ET
on The Wall Street Journal














Recent News



Other News
Press Releases






Why Heska (HSKA) Could Be Positioned for a Surge
Heska (HSKA) is seeing positive earnings estimate revisions suggesting that it could be a solid choice for investors.

Jun. 2, 2017 at 8:46 a.m. ET
on Zacks.com





5 Top Efficient Stocks to Boost Your Portfolio
A company with a favorable efficiency level is expected to provide impressive returns as it is positively correlated with the price performance.

May. 4, 2017 at 7:59 a.m. ET
on Zacks.com





Exelixis (EXEL) Posts Earnings in Q1, Cabometyx in Focus
Exelixis posted earnings in the first quarter of 2017 while revenues beat estimates driven by Cabometyx. 

May. 2, 2017 at 4:09 p.m. ET
on Zacks.com





Radius Health (RDUS) Posts Wider Q1 Loss, Tymlos Approved 
Radius Health, Inc. (RDUS) posted a wider-than-expected loss of $1.32 per share in the first quarter of 2017 which were overshadowed by the approval of Tymlos. 

May. 2, 2017 at 3:39 p.m. ET
on Zacks.com





CVS Health (CVS) Q1 Earnings Beat Estimates, Decrease Y/Y
CVS Health Corporation (CVS) reported first-quarter 2017 adjusted earnings per share (EPS) of $1.17, down 0.8% year over year. 

May. 2, 2017 at 10:41 a.m. ET
on Zacks.com





Hill-Rom (HRC) Beats Earnings & Revenue Estimates in Q2
Hill-Rom Holdings, Inc. (HRC) reported second-quarter fiscal 2017 adjusted earnings per share (EPS) of 88 cents, up 23.9% from the year-ago quarter.

May. 1, 2017 at 9:59 a.m. ET
on Zacks.com





10-Q: HESKA CORP
10-Q: HESKA CORP

May. 5, 2017 at 6:05 a.m. ET
on Edgar Online -  (EDG = 10Q, 10K)





AbbVie (ABBV) Q1 Earnings Beat Estimates, Revenues Up Y/Y
AbbVie Inc. (ABBV) reported better-than-expected results in the first-quarter of 2017. The company surpassed both earnings and sales expectations.

Apr. 27, 2017 at 4:52 p.m. ET
on Zacks.com





Bayer (BAYRY) Beats Q1 Earnings, Revenue Estimates 
Bayer AG's (BAYRY) first-quarter 2017 core earnings per share from continuing operations was $2.80 which beat the Zacks Consensus Estimate of $2.40. 

Apr. 27, 2017 at 2:59 p.m. ET
on Zacks.com





Alexion (ALXN) Tops Q1 Earnings, Revenues; Ups '17 View
Alexion Pharmaceuticals, Inc.'s (ALXN) first-quarter 2017 earnings (including stock-based compensation expense) of $1.20 per share compared with the year ago earnings of 76 cents. The reported figure surpassed the Zacks Consensus Estimate of $1.05.

Apr. 27, 2017 at 2:42 p.m. ET
on Zacks.com





The Medicines Company (MDCO) Q1 Loss Wider Than Expected
The Medicines Company (MDCO) reported loss $1.44 per share, wider than the Zacks Consensus Estimate of a loss of $1.13.

Apr. 27, 2017 at 9:52 a.m. ET
on Zacks.com





Chemed's (CHE) Earnings and Revenues Beat Estimates in Q1
Chemed Corp.'s (CHE) first-quarter 2017 adjusted earnings per share (EPS) (considering stock-based compensation expense and related tax benefit as a regular one) were $1.92, as compared to the year-ago adjusted EPS figure of $1.52, up 26.3% year over year.

Apr. 27, 2017 at 9:03 a.m. ET
on Zacks.com





Heska's (HSKA) CEO Kevin Wilson on Q1 2017 Results - Earnings Call Transcript
Heska's (HSKA) CEO Kevin Wilson on Q1 2017 Results - Earnings Call Transcript

May. 2, 2017 at 4:03 p.m. ET
on Seeking Alpha





Here's Why Heska Corporation Is Dropping Today


May. 2, 2017 at 12:33 p.m. ET
on Motley Fool





Notable earnings before Tuesday’s open
Notable earnings before Tuesday’s open

May. 1, 2017 at 5:30 p.m. ET
on Seeking Alpha





Sarepta (SRPT) Q1 Loss Narrows, Exondys 51 Sales Pick Up
Sarepta Therapeutics, Inc. (SRPT) reported narrower-than-expected loss in the first quarter of 2017. Meanwhile, the biotech company increased its 2017 sales outlook for Exondys 51 as patient and physician interest for the drug increased

Apr. 28, 2017 at 10:43 a.m. ET
on Zacks.com





Acorda (ACOR) Q1 Loss Wider Than Expected, Revenues Miss 
Acorda Therapeutics, Inc. (ACOR) reported loss of 25 cents per share in the first quarter of 2017 (including the impact of stock-based compensation expenses), wider than the Zacks Consensus Estimate of a loss of 16 cents. 

Apr. 28, 2017 at 10:29 a.m. ET
on Zacks.com





AstraZeneca (AZN) Q1 Earnings Beat, Revenues Meet Estimates
AstraZeneca PLC (AZN) reported first-quarter 2017 core earnings of 99 cents per American Depositary Share, which comfortably beat the Zacks Consensus Estimate of 38 cents. 

Apr. 28, 2017 at 10:31 a.m. ET
on Zacks.com





Align Technology (ALGN) Beats on Q1 Earnings and Revenues
Align Technology Inc. (ALGN) reported adjusted earnings per share (EPS) of 85 cents in the first quarter of 2017, up 70% from 50 cents posted in the year-ago quarter. 

Apr. 28, 2017 at 9:31 a.m. ET
on Zacks.com





Seattle Genetics (SGEN) Q1 Loss Widens, Sales Top Estimates
Seattle Genetics, Inc. (SGEN) reported a loss of 42 cents per share for the first quarter of 2017, wider than the Zacks Consensus Estimate of a loss of 41 cents and the year-ago loss of 15 cents per share.

Apr. 28, 2017 at 9:57 a.m. ET
on Zacks.com









Heska to Present at Canaccord Genuity 37th Annual Growth Conference on August 10
Heska to Present at Canaccord Genuity 37th Annual Growth Conference on August 10

Jul. 20, 2017 at 4:05 p.m. ET
on PR Newswire - PRF





Heska Schedules Second Quarter 2017 Financial Results Conference Call for July 31, 2017
Heska Schedules Second Quarter 2017 Financial Results Conference Call for July 31, 2017

Jul. 11, 2017 at 8:00 a.m. ET
on PR Newswire - PRF





Scott Humphrey Joins Heska's Board of Directors
Scott Humphrey Joins Heska's Board of Directors

Jun. 13, 2017 at 9:00 a.m. ET
on PR Newswire - PRF





Investor Network: Heska Corporation to Host Earnings Call
Investor Network: Heska Corporation to Host Earnings Call

May. 2, 2017 at 8:05 a.m. ET
on ACCESSWIRE





Heska Reports First Quarter Results
Heska Reports First Quarter Results

May. 2, 2017 at 8:00 a.m. ET
on PR Newswire - PRF





Heska To Present at Four Upcoming Conferences
Heska To Present at Four Upcoming Conferences

Apr. 27, 2017 at 8:00 a.m. ET
on PR Newswire - PRF





Reminder: Heska Annual Meeting of Stockholders on May 1, 2017
Reminder: Heska Annual Meeting of Stockholders on May 1, 2017

Apr. 25, 2017 at 5:20 p.m. ET
on PR Newswire - PRF





Heska Schedules First Quarter 2017 Financial Results Conference Call for May 2, 2017


Apr. 13, 2017 at 8:00 a.m. ET
on PR Newswire - PRF





Heska Schedules Annual Meeting of Stockholders for May 1, 2017


Apr. 12, 2017 at 8:00 a.m. ET
on PR Newswire - PRF





Gartner Set to Join S&P 500; Dun & Bradstreet, Wintrust Financial and INC Research to Join S&P MidCap 400; Heska to Join S&P SmallCap 600


Mar. 29, 2017 at 6:21 p.m. ET
on PR Newswire - PRF





Post Earnings Coverage as VWR Corp. Q4 2016 Results Outperformed Projections


Mar. 14, 2017 at 8:23 a.m. ET
on ACCESSWIRE





Heska Reports Record Quarter and Annual Results


Feb. 28, 2017 at 8:00 a.m. ET
on PR Newswire - PRF





Heska Schedules Fourth Quarter and Year-End 2016 Financial Results Conference Call for February 28, 2017


Jan. 31, 2017 at 4:27 p.m. ET
on PR Newswire - PRF





Heska to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum on November 17


Nov. 3, 2016 at 8:00 a.m. ET
on PR Newswire - PRF





Heska Reports Record Third Quarter Results


Nov. 1, 2016 at 8:00 a.m. ET
on PR Newswire - PRF





Heska Schedules Third Quarter 2016 Earnings Release and Conference Call for November 1, 2016


Oct. 19, 2016 at 8:00 a.m. ET
on PR Newswire - PRF





Heska Announces Executive Promotions to Further Growth Initiatives


Sep. 29, 2016 at 5:35 p.m. ET
on PR Newswire - PRF





Heska to Present at CL King's 14th Annual Best Ideas Conference 2016 on September 13


Sep. 6, 2016 at 9:00 a.m. ET
on PR Newswire - PRF





Heska to Present at CL King's 14th Annual Best Ideas Conference 2016 on September 13


Sep. 6, 2016 at 9:00 a.m. ET
on PR Newswire - PRF





Heska to Present at Canaccord Genuity 36th Annual Growth Conference on August 10, 2016


Aug. 4, 2016 at 12:00 p.m. ET
on PR Newswire - PRF











Heska Corp.


            
            Heska Corp. engages in the research, development and manufacture of veterinary products. The company operates through two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals & Products. The Core Companion Animal Health segment supplies blood testing instruments, digital imaging software, heartworm diagnostic tests and preventive products, allergy immunotherapy products, and allergy testing. The Other Vaccines, Pharmaceuticals and Products segment develops and distributes vaccines and pharmaceutical products. Its solutions include, dri-chem 4000, 7000, hematrue, element ht5, element i and solo step heartworm. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

            
            (See Full Profile)


  




Analyst Ratings



Sell
Under
Hold
Over
Buy

Number of Ratings 7
Full Ratings 





Benzinga's Top Initiations


Nov. 29, 2016 at 9:22 a.m. ET
on Benzinga.com





Canaccord Fireside Chat Takeaways For Abaxis, Heska


Aug. 16, 2016 at 4:00 p.m. ET
on Benzinga.com





Benzinga's Top Initiations


Apr. 1, 2016 at 9:33 a.m. ET
on Benzinga.com





 


Competitors




Name
Chg %
Market Cap




Abaxis Inc.
-1.24%
$1.16B


IDEXX Laboratories Inc.
-0.40%
$14.68B


Immucell Corp.
-0.15%
$31.8M


VCA Inc.
0.01%
$7.51B


Novartis AG ADR
-0.50%
$221.79B




Competitor Data Provided By


   






   



























Partner Content























Trending Tickers
Powered by 





APRN

0.46%








GNCA

2.02%








DVAX

0.52%








WBMD

-0.11%








PETS

3.98%
























Advanced Search







Stocks



Columns


Authors


Topics







No results found





























Video Center










Learn more.Storyful, a division of News Corp, which owns MarketWatch, is a leading social media services company headquartered in Dublin, Ireland. Storyful combines world class journalism with industry-leading technology to discover, verify and acquire original content and provide the on-the-ground sources news and media organizations need to tell the stories that matter to their audience.













Stocks Index - Markets Index
























Bulletin






Investor Alert







New York Markets Open in:



Market Snapshot
Analyst Ratings
















Stocks
Rates
Funds
Bonds
Benchmarks
Real Estate Investment Trusts
Futures
American Depository Receipt Stocks
Exchange Traded Notes
Warrants
Indexes
Exchange Traded Funds
Currencies
Crypto Currencies

Browse Stocks
Stocks A-Z


0-9ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Browse by Location

Argentina
Australia
Austria
Bahamas
Bahrain
Belgium
Bermuda
Botswana
Brazil
British Virgin Islands
Canada
Cayman Islands
Chile
China
Colombia
Curacao
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Gibraltar
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Isle of Man
Israel
Italy
Japan
Jordan
Kazakhstan
Kuwait
Latvia
Lebanon
Liechtenstein
Lithuania
Luxembourg
Malaysia
Malta
Mauritius
Mexico
Monaco
Money Rates
Morocco
Namibia
Netherlands
New Zealand
Norway
Oman
Pakistan
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United States
Venezuela
Western Samoa












Log In




8:48 AM EDT
July 24, 2017


/marketstate/country/us
New York

	Pre


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
8:48aDollar edges higher ahead of Fed meeting, but remains sharply lower for July
8:47aCharges dropped after ‘London Whale’ accused Jamie Dimon of making him a fall guy
8:46aGold tries to run up streak of gains to 7 sessions
8:46aAmerican workers are slaves to their emails — these digital organizers aim to help
8:45aU.S. stocks search for direction as busy earnings week gets under way
8:44aThis app will analyze your DNA to help you lose weight
8:43aJ.C. Penney accepting Apple Pay nationwide
8:43aPandora Media shares gain more than 4% premarket after upbeat analyst note
8:40aArconic shares surge 6% premarket after company beats on profit, raises outlook
8:38aRepublican health bill still mystery before vote | Trump averaged 50% or higher approval in 17 states   
8:37aArconic to no longer sell the Reynobond PE product used in high-rise construction
8:35aArconic's stock soars 4.9% premarket after Q2 results
8:34aArconic raises 2017 revenue outlook to $12.3 bln-$12.7 bln from $11.8 bln-$12.4 bln
8:34aArconic raises 2017 adj. EPS outlook to $1.15-$1.20 from $1.10-$1.20
8:33aArconic Q2 revenue $3.26 bln vs. $3.23 bln a year ago; FactSet consensus $3.20 bln
8:33aArconic Q2 adj. EPS 32 cents; FactSet consensus 26 cents
8:32aArconic Q2 EPS 43 cents vs. 27 cents a year ago
8:31aPussy Riot is raising $80,000 so everyone can experience Russian prisons
8:24aVice Media lays off 2% of staff as focus turns more toward video
8:24aSchlumberger stock price target cut to $93 from $107 at FBR & Co.
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,580.07

-31.71
-0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,387.75

-2.25
-0.04%





s&p 500

/quotes/zigman/3870025/realtime
2,472.54

-0.91
-0.04%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15



















































Stocks Index - Markets Index
























Bulletin






Investor Alert







New York Markets Open in:



Market Snapshot
Analyst Ratings
















Stocks
Rates
Funds
Bonds
Benchmarks
Real Estate Investment Trusts
Futures
American Depository Receipt Stocks
Exchange Traded Notes
Warrants
Indexes
Exchange Traded Funds
Currencies
Crypto Currencies

Browse Stocks
Stocks A-Z


0-9ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Browse by Location

Argentina
Australia
Austria
Bahamas
Bahrain
Belgium
Bermuda
Botswana
Brazil
British Virgin Islands
Canada
Cayman Islands
Chile
China
Colombia
Curacao
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Gibraltar
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Isle of Man
Israel
Italy
Japan
Jordan
Kazakhstan
Kuwait
Latvia
Lebanon
Liechtenstein
Lithuania
Luxembourg
Malaysia
Malta
Mauritius
Mexico
Monaco
Money Rates
Morocco
Namibia
Netherlands
New Zealand
Norway
Oman
Pakistan
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United States
Venezuela
Western Samoa












Log In




8:48 AM EDT
July 24, 2017


/marketstate/country/us
New York

	Pre


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
8:48aDollar edges higher ahead of Fed meeting, but remains sharply lower for July
8:47aCharges dropped after ‘London Whale’ accused Jamie Dimon of making him a fall guy
8:46aGold tries to run up streak of gains to 7 sessions
8:46aAmerican workers are slaves to their emails — these digital organizers aim to help
8:45aU.S. stocks search for direction as busy earnings week gets under way
8:44aThis app will analyze your DNA to help you lose weight
8:43aJ.C. Penney accepting Apple Pay nationwide
8:43aPandora Media shares gain more than 4% premarket after upbeat analyst note
8:40aArconic shares surge 6% premarket after company beats on profit, raises outlook
8:38aRepublican health bill still mystery before vote | Trump averaged 50% or higher approval in 17 states   
8:37aArconic to no longer sell the Reynobond PE product used in high-rise construction
8:35aArconic's stock soars 4.9% premarket after Q2 results
8:34aArconic raises 2017 revenue outlook to $12.3 bln-$12.7 bln from $11.8 bln-$12.4 bln
8:34aArconic raises 2017 adj. EPS outlook to $1.15-$1.20 from $1.10-$1.20
8:33aArconic Q2 revenue $3.26 bln vs. $3.23 bln a year ago; FactSet consensus $3.20 bln
8:33aArconic Q2 adj. EPS 32 cents; FactSet consensus 26 cents
8:32aArconic Q2 EPS 43 cents vs. 27 cents a year ago
8:31aPussy Riot is raising $80,000 so everyone can experience Russian prisons
8:24aVice Media lays off 2% of staff as focus turns more toward video
8:24aSchlumberger stock price target cut to $93 from $107 at FBR & Co.
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,580.07

-31.71
-0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,387.75

-2.25
-0.04%





s&p 500

/quotes/zigman/3870025/realtime
2,472.54

-0.91
-0.04%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15



















































Stocks/Country/United States Index - Markets Index
























Bulletin






Investor Alert







New York Markets Open in:



Market Snapshot
Analyst Ratings
















Stocks
Rates
Funds
Bonds
Benchmarks
Real Estate Investment Trusts
Futures
American Depository Receipt Stocks
Exchange Traded Notes
Warrants
Indexes
Exchange Traded Funds
Currencies
Crypto Currencies

Location: United States



Name
Exchange
Sector




01 Communique Laboratory Inc. (OCQLF)
OOTC
Software


1347 Property Insurance Holdings Inc. (PIH)
XNAS
Non-Life Insurance


1-800-FLOWERS.COM Inc. Cl A (FLWS)
XNAS
Specialty Retail


1pm Industries Inc. (OPMZ)
OOTC
Food Products


1st Capital Bank (CA) (FISB)
OOTC
Banking


1st Constitution Bancorp (FCCY)
XNAS
Banking


1st NRG Corp. (FNRC)
OOTC
Oil Extraction


1st Source Corp. (SRCE)
XNAS
Banking


2050 Motors Inc. (ETFM)
OOTC
Automobiles


21st Century Fox Inc. Cl A (FOXA)
XNAS
Broadcasting


21st Century Fox Inc. Cl B (FOX)
XNAS
Broadcasting


21Vianet Group Inc. ADR (VNET)
XNAS
Internet/Online


22nd Century Group Inc. (XXII)
XASE
Biotechnology


24/7 Kid Doc Inc. (TVMD)
OOTC
Healthcare Provision


2U Inc. (TWOU)
XNAS
Software


2xLeveraged Long E-TRACS Linked to Wells Fargo Business Development Co. Index 052441 (BDCL)
ARCX
Major International Banks


2xLeveraged Long ETRACS Wells Fargo Business Development (LBDC)
ARCX
Major International Banks


3D Eye Solutions Inc. (TDEY)
OOTC
Motion Picture/Sound Recording


3D Pioneer Systems Inc. (DPSM)
OOTC
Software


3D Systems Corp. (DDD)
XNYS
Computers/Consumer Electronics


3DIcon Corp. (TDCP)
OOTC
Software


3Dshopping.com (THDS)
OOTC
Mixed Retailing


3DX Industries Inc. (DDDX)
OOTC
Computers/Consumer Electronics


3i Group PLC ADR (TGOPY)
OOTC
Finance Companies


3M Co. (MMM)
XNYS
Diversified Holding Companies


3Pea International Inc. (TPNL)
XOTC
Accounting


3Power Energy Group Inc. (PSPW)
OOTC
Renewable Energy Generation


3TL Technologies Corp. (TTMZF)
OOTC
Advertising/Marketing/Public Relations


420 Property Management Inc. (FTPM)
OOTC
Real Estate Agents/Brokers


4Cable TV International Inc. (CATV)
OOTC
Diversified Business Services


4Licensing Corp. (FOURQ)
OOTC
Diversified Business Services


500.com Ltd. ADR (WBAI)
XNYS
Gambling Industries


51job Inc. ADR (JOBS)
XNAS
Employment/Training Services


58.com Inc. ADR (WUBA)
XNYS
Consumer Services


5Barz International Inc. (BARZ)
OOTC
Networking


5N Plus Inc. (FPLSF)
OOTC
Commodity Chemicals


6D Global Technologies Inc. (SIXD)
OOTC
Computer Services


808 Renewable Energy Corp. (RNWR)
OOTC
Multiutilities


88 Energy Ltd. ADR (TNGRY)
OOTC
Oil Extraction


888 Holdings PLC (EIHDF)
OOTC
Gambling Industries


8Point3 Energy Partners LP (CAFD)
XNAS
Renewable Energy Generation


8X8 Inc. (EGHT)
XNAS
Wired Telecommunications Services


A Clean Slate Inc. (DRWN)
OOTC
Diversified Business Services


A&W Revenue Royalties Income Fund (AWRRF)
OOTC
Restaurants


A. H. Belo Corp. Series A (AHC)
XNYS
Publishing


A. Schulman Inc. (SHLM)
XNAS
Commodity Chemicals


A. Schulman Inc. 6% Pfd. (SLMNP)
OOTC
Commodity Chemicals


A.D. Makepeace Co. (MAKE)
OOTC
Farming


A.M. Castle & Co. (CAS)
XNYS
Wholesalers


A.O. Smith Corp. (AOS)
XNYS
Building Materials/Products


A.P. Moeller-Maersk A/S ADR (AMKBY)
OOTC
Water Transport/Shipping


A.P. Moeller-Maersk A/S Series A (AMKAF)
OOTC
Water Transport/Shipping


A.P. Moeller-Maersk A/S Series B (AMKBF)
OOTC
Water Transport/Shipping


A.S. Roma S.p.A. (ASRAF)
OOTC
Recreational Services


A-1 Group Inc. (AWON)
OOTC
Tobacco


A10 Networks Inc. (ATEN)
XNYS
Computer Services


a2 Milk Co. Ltd. (ACOPF)
OOTC
Biotechnology


AAC Holdings Inc. (AAC)
XNYS
Healthcare Provision


AAC Technologies Holdings Inc. (AACAF)
OOTC
Industrial Electronics


AAC Technologies Holdings Inc. ADR (AACAY)
OOTC
Industrial Electronics


AAON Inc. (AAON)
XNAS
Building Materials/Products


AAP Inc. (AAPJ)
OOTC
Food Products


AAR Corp. (AIR)
XNYS
Aerospace Products/Parts


Aaron's Inc. (AAN)
XNYS
Consumer Services


AB Science S.A. (ABSCF)
OOTC
Pharmaceuticals


AB Svensk Exportkredit ELEMENTS linked to MLCX Biofuels Index Total Return (FUE)
ARCX
Finance Companies


AB Svensk Exportkredit ELEMENTS linked to MLCX Grain Index Total Return (GRU)
ARCX
Finance Companies


AB&T Financial Corp. (ABTO)
OOTC
Banking


Abacus Mining & Exploration Corp. (ABCFF)
OOTC
General Mining


Abakan Inc. (ABKI)
OOTC
Industrial Products


Abattis Bioceuticals Corp. (ATTBF)
OOTC
Biotechnology


Abaxis Inc. (ABAX)
XNAS
Medical Equipment/Supplies


ABB Ltd. (ABLZF)
OOTC
Industrial Machinery


ABB Ltd. ADR (ABB)
XNYS
Industrial Machinery


Abbott Laboratories (ABT)
XNYS
Pharmaceuticals


AbbVie Inc. (ABBV)
XNYS
Biotechnology


Abby Inc. (ABBY)
OOTC
Oil Extraction


Abcam PLC (ABCZF)
OOTC
Biotechnology


Abcam PLC ADR (ABCZY)
OOTC
Biotechnology


ABCO Energy Inc. (ABCE)
OOTC
Industrial Machinery


Abcourt Mines Inc. (ABMBF)
OOTC
General Mining


Aben Resources Ltd. (ABNAF)
OOTC
General Mining


Abengoa S.A. B (AGOAF)
OOTC
Construction


Abeona Therapeutics Inc. (ABEO)
XNAS
Biotechnology


Abeona Therapeutics Inc. Wt (ABEOW)
XNAS



Abercrombie & Fitch Co. (ANF)
XNYS
Clothing Retail


Aberdeen Asia-Pacific Income Fund Inc. (FAX)
XASE
Closed-End Funds


Aberdeen Asia-Pacific Income Investment Co. Ltd. (ABAKF)
OOTC
Closed-End Funds


Aberdeen Asset Management PLC (ABDNF)
OOTC
Investment Advisors


Aberdeen Asset Management PLC ADR (ABDNY)
OOTC
Investment Advisors


Aberdeen Australia Equity Fund Inc. (IAF)
XASE
Closed-End Funds


Aberdeen Chile Fund Inc. (CH)
XASE
Closed-End Funds


Aberdeen Emerging Markets Smaller Company Opportunities Fund Inc. (ABE)
XASE
Closed-End Funds


Aberdeen Global Income Fund Inc. (FCO)
XASE
Closed-End Funds


Aberdeen Greater China Fund Inc. (GCH)
XNYS
Closed-End Funds


Aberdeen Indonesia Fund Inc. (IF)
XASE
Closed-End Funds


Aberdeen International Inc. (AABVF)
OOTC
General Mining


Aberdeen Israel Fund Inc. (ISL)
XASE
Closed-End Funds


Aberdeen Japan Equity Fund Inc. (JEQ)
XNYS
Closed-End Funds


Aberdeen Latin America Equity Fund Inc. (LAQ)
XASE
Closed-End Funds


Aberdeen Singapore Fund Inc. (SGF)
XNYS
Closed-End Funds


Abertis Infraestructuras S.A. ADR (ABRTY)
OOTC
Transportation Services


Ability Inc. (ABIL)
XNAS
Precision Products


Ability Inc. Wt (ABIWF)
OOTC



Abiomed Inc. (ABMD)
XNAS
Medical Equipment/Supplies


Abitibi Royalties Inc. (ATBYF)
OOTC
General Mining


Able Energy Inc. (ABLE)
OOTC
Gas Utilities


Ablynx N.V. (ABLYF)
OOTC
Biotechnology


ABM Industries Inc. (ABM)
XNYS
Diversified Business Services


Abraxas Petroleum Corp. (AXAS)
XNAS
Oil Extraction


Absecon Bancorp (ASCN)
OOTC
Banking


Absolute Health & Fitness Inc. (AHFI)
OOTC
Recreational Services


Absolute Software Corp. (ALSWF)
OOTC
Software


ABT Holdings Inc. (ABOT)
OOTC
Precious Metals


Abtech Holdings Inc. (ABHD)
OOTC
Industrial Machinery


ABV Consulting Inc. (ABVN)
OOTC
Advertising/Marketing/Public Relations


AC Immune S.A. (ACIU)
XNAS
Biotechnology


Acacia Communications Inc. (ACIA)
XNAS
Networking


Acacia Diversified Holdings Inc. (ACCA)
OOTC
Specialty Retail


Acacia Mining PLC (ABGLF)
OOTC
Gold


Acacia Research Corp. - Acacia Technologies (ACTG)
XNAS
Diversified Business Services


Acadia Healthcare Co. Inc. (ACHC)
XNAS
Healthcare Provision


ACADIA Pharmaceuticals Inc. (ACAD)
XNAS
Biotechnology


Acadia Realty Trust (AKR)
XNYS



Acadian Timber Corp. (ACAZF)
OOTC
Forestry & Wood Products


Acasti Pharma Inc. (ACST)
XNAS
Pharmaceuticals


Accelera Innovations Inc. (ACNV)
OOTC
Healthcare Provision


Accelerate Diagnostics Inc. (AXDX)
XNAS
Biotechnology


Accelerize Inc. (ACLZ)
XOTC
Life Insurance


Acceleron Pharma Inc. (XLRN)
XNAS
Biotechnology


Accenture PLC Cl A (ACN)
XNYS
Diversified Business Services


Access National Corp. (ANCX)
XNAS
Banking


Access Power Inc. (ACCR)
OOTC
Wired Telecommunications Services


Access Worldwide Communications Inc. (AWWC)
OOTC
Advertising/Marketing/Public Relations


Acciona S.A. (ACXIF)
OOTC
Construction


ACCO Brands Corp. (ACCO)
XNYS
Nondurable Household Products


Accor S.A. (ACRFF)
OOTC
Hotels


Accor S.A. ADR (ACCYY)
OOTC
Hotels


Accordia Golf Co. Ltd. (ACGFF)
OOTC
Recreational Services


Accredited Mortgage Loan REIT Trust 9.75% Perp. Cum. Pfd. Series A (AHHAP)
OOTC
Mortgages


Accretive Health Inc. (ACHI)
OOTC
Healthcare Provision


Accuray Inc. (ARAY)
XNAS
Medical Equipment/Supplies


Accuride Corp. (ACW)
XNYS
Auto & Commercial Vehicle Parts


AcelRx Pharmaceuticals Inc. (ACRX)
XNAS
Pharmaceuticals


Acer Inc. GDR Reg S (ACEYY)
OOTC
Computers/Consumer Electronics


Acerus Pharmaceuticals Corp. (TRLPF)
OOTC
Biotechnology


Aceto Corp. (ACET)
XNAS
Specialty Chemicals


Achaogen Inc. (AKAO)
XNAS
Biotechnology


Achillion Pharmaceuticals Inc. (ACHN)
XNAS
Biotechnology


ACI Worldwide Inc. (ACIW)
XNAS
Software



«1234567891011-2021-3031-4041-5051-6061-7071-8081-9091-94»










Log In




8:48 AM EDT
July 24, 2017


/marketstate/country/us
New York

	Pre


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
8:48aDollar edges higher ahead of Fed meeting, but remains sharply lower for July
8:47aCharges dropped after ‘London Whale’ accused Jamie Dimon of making him a fall guy
8:46aGold tries to run up streak of gains to 7 sessions
8:46aAmerican workers are slaves to their emails — these digital organizers aim to help
8:45aU.S. stocks search for direction as busy earnings week gets under way
8:44aThis app will analyze your DNA to help you lose weight
8:43aJ.C. Penney accepting Apple Pay nationwide
8:43aPandora Media shares gain more than 4% premarket after upbeat analyst note
8:40aArconic shares surge 6% premarket after company beats on profit, raises outlook
8:38aRepublican health bill still mystery before vote | Trump averaged 50% or higher approval in 17 states   
8:37aArconic to no longer sell the Reynobond PE product used in high-rise construction
8:35aArconic's stock soars 4.9% premarket after Q2 results
8:34aArconic raises 2017 revenue outlook to $12.3 bln-$12.7 bln from $11.8 bln-$12.4 bln
8:34aArconic raises 2017 adj. EPS outlook to $1.15-$1.20 from $1.10-$1.20
8:33aArconic Q2 revenue $3.26 bln vs. $3.23 bln a year ago; FactSet consensus $3.20 bln
8:33aArconic Q2 adj. EPS 32 cents; FactSet consensus 26 cents
8:32aArconic Q2 EPS 43 cents vs. 27 cents a year ago
8:31aPussy Riot is raising $80,000 so everyone can experience Russian prisons
8:24aVice Media lays off 2% of staff as focus turns more toward video
8:24aSchlumberger stock price target cut to $93 from $107 at FBR & Co.
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,580.07

-31.71
-0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,387.75

-2.25
-0.04%





s&p 500

/quotes/zigman/3870025/realtime
2,472.54

-0.91
-0.04%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15


















































HSKA Stock Price - Heska Corp. Stock Quote (U.S.: Nasdaq) - MarketWatch



























 














































 















Sections

Watchlist




























Signup
 • 
Login

Search







Bulletin











US
Europe
Asia
FX
Rates
Futures


Range


1D
5D
1M
3M
6M
1Y
2Y











DJIA F

21,514


-4


-0.02%











S&P F

2,469.00


-0.50


-0.02%











NASDAQ F

5,921.00


2.25


0.04%











Gold

1,264.30


3.30


0.26%











Silver

16.565


0.108


0.66%











Crude Oil

45.97


0.20


0.44%

















S&P 500 Movers(%)



CTAS 
9.2




COF 
8.6




ETFC 
5.1




SYF 
4.5






HP
-5.5




ISRG
-4.6




HBAN
-4.4




CHK
-3.1














Latest NewsAll Times Eastern








8:47a

Updated
Dollar edges higher ahead of Fed meeting, but remains sharply lower for July



8:46a

Updated
Charges dropped after ‘London Whale’ accused Jamie Dimon of making him a fall guy



8:46a

Updated
Gold tries to run up streak of gains to 7 sessions



8:45a

Updated
American workers are slaves to their emails — these digital organizers aim to help



8:45a

Updated
U.S. stocks search for direction as busy earnings week gets under way



8:43a

Updated
This app will analyze your DNA to help you lose weight



8:43a

J.C. Penney accepting Apple Pay nationwide



8:42a

Pandora Media shares gain more than 4% premarket after upbeat analyst note



8:39a

Arconic shares surge 6% premarket after company beats on profit, raises outlook



8:38a

Republican health bill still mystery before vote | Trump averaged 50% or higher approval in 17 states   












to be replaced

























































































































    




Home


Investing


Quotes


Stocks


United States


HSKA


Overview



Compare Quotes
Stock Screener
Earnings Calendar
Sectors
Nasdaq

 



HSKA
U.S.: Nasdaq


Join TD Ameritrade

Find a Broker


Heska Corp.

Watchlist 
CreateHSKAAlert



  


After Hours

Last Updated: Jul 21, 2017 4:22 p.m. EDT
Delayed quote



$
100.17



0.00
0.00%



After Hours Volume:
545





Close
Chg
Chg %




$100.17
-1.24
-1.22%





  









Advanced Charting


1D
5D
1M
3M
6M
YTD
1Y
3Y
All




$
%
Vol


Advanced Charting

  




49.22% vs Avg.




                Volume:               
                
                    41.9K
                


                65 Day Avg. - 85.2K
            





Open: 102.52
Close: 100.17



99.9900
Day Low/High
102.7500





Day Range



41.2300
52 Week Low/High
110.2500


   








Your Watchlist



Customize MarketWatch
Have Watchlists? Log in to see them here or sign up to get started.

Create Account

                    … or Log In

















Symbol
Last
Chg
Chg %

















No Items in Watchlist
There are currently no items in this Watchlist.

Add Ticker to Watchlist




 (Go to Your Watchlist) 




No Saved Watchlists
Create a list of the investments you want to track.

Create Watchlist

                    …or try this starter list






Uh oh
Something went wrong while loading Watchlist.

Go to Watchlist



 

Recently Viewed Tickers



No Recent Tickers
Visit a quote page and your recently viewed tickers will be displayed here.

Search Tickers



















   





Overview


Profile


News


Charts


Financials


Historical Quotes


Analyst Estimates


Options


SEC Filings


Insiders



   




Key Data



Open
$102.52



Day Range
99.9900 - 102.7500



52 Week Range
41.2300 - 110.2500



Market Cap
$712.81M



Shares Outstanding
7.12M



Public Float
6.42M



Beta
0.60



Rev. per Employee
$407.7K



P/E Ratio
53.57



EPS
$1.87



Yield
n/a



Dividend
$0.10



Ex-Dividend Date
Sep 26, 2012



Short Interest
236.21K
06/30/17


% of Float Shorted
3.68%



Average Volume
85.19K




 


Performance




5 Day


-0.61%







1 Month


2.74%







3 Month


-4.75%







YTD


39.90%







1 Year


136.47%









  

 
 


Recent News



MarketWatch
Other Dow Jones











The top-performing stocks from each region around the world

Feb. 19, 2017 at 7:43 p.m. ET
by Shawn Langlois









Heska downgraded to neutral from buy at B. Riley


Sep. 22, 2016 at 8:11 a.m. ET
by Tomi Kilgore









Heska downgraded to neutral from buy at B. Riley


Sep. 21, 2016 at 10:09 a.m. ET
by Tomi Kilgore










Stocks to watch Friday: Goldman, Bally, Scotts

Aug. 10, 2012 at 6:54 a.m. ET
by MarketWatch














Stocks to Watch: Jabil, Kraft, Biogen

Sep. 26, 2012 at 9:08 a.m. ET
on The Wall Street Journal














Recent News



Other News
Press Releases






Why Heska (HSKA) Could Be Positioned for a Surge
Heska (HSKA) is seeing positive earnings estimate revisions suggesting that it could be a solid choice for investors.

Jun. 2, 2017 at 8:46 a.m. ET
on Zacks.com





5 Top Efficient Stocks to Boost Your Portfolio
A company with a favorable efficiency level is expected to provide impressive returns as it is positively correlated with the price performance.

May. 4, 2017 at 7:59 a.m. ET
on Zacks.com





Exelixis (EXEL) Posts Earnings in Q1, Cabometyx in Focus
Exelixis posted earnings in the first quarter of 2017 while revenues beat estimates driven by Cabometyx. 

May. 2, 2017 at 4:09 p.m. ET
on Zacks.com





Radius Health (RDUS) Posts Wider Q1 Loss, Tymlos Approved 
Radius Health, Inc. (RDUS) posted a wider-than-expected loss of $1.32 per share in the first quarter of 2017 which were overshadowed by the approval of Tymlos. 

May. 2, 2017 at 3:39 p.m. ET
on Zacks.com





CVS Health (CVS) Q1 Earnings Beat Estimates, Decrease Y/Y
CVS Health Corporation (CVS) reported first-quarter 2017 adjusted earnings per share (EPS) of $1.17, down 0.8% year over year. 

May. 2, 2017 at 10:41 a.m. ET
on Zacks.com





Hill-Rom (HRC) Beats Earnings & Revenue Estimates in Q2
Hill-Rom Holdings, Inc. (HRC) reported second-quarter fiscal 2017 adjusted earnings per share (EPS) of 88 cents, up 23.9% from the year-ago quarter.

May. 1, 2017 at 9:59 a.m. ET
on Zacks.com





10-Q: HESKA CORP
10-Q: HESKA CORP

May. 5, 2017 at 6:05 a.m. ET
on Edgar Online -  (EDG = 10Q, 10K)





AbbVie (ABBV) Q1 Earnings Beat Estimates, Revenues Up Y/Y
AbbVie Inc. (ABBV) reported better-than-expected results in the first-quarter of 2017. The company surpassed both earnings and sales expectations.

Apr. 27, 2017 at 4:52 p.m. ET
on Zacks.com





Bayer (BAYRY) Beats Q1 Earnings, Revenue Estimates 
Bayer AG's (BAYRY) first-quarter 2017 core earnings per share from continuing operations was $2.80 which beat the Zacks Consensus Estimate of $2.40. 

Apr. 27, 2017 at 2:59 p.m. ET
on Zacks.com





Alexion (ALXN) Tops Q1 Earnings, Revenues; Ups '17 View
Alexion Pharmaceuticals, Inc.'s (ALXN) first-quarter 2017 earnings (including stock-based compensation expense) of $1.20 per share compared with the year ago earnings of 76 cents. The reported figure surpassed the Zacks Consensus Estimate of $1.05.

Apr. 27, 2017 at 2:42 p.m. ET
on Zacks.com





The Medicines Company (MDCO) Q1 Loss Wider Than Expected
The Medicines Company (MDCO) reported loss $1.44 per share, wider than the Zacks Consensus Estimate of a loss of $1.13.

Apr. 27, 2017 at 9:52 a.m. ET
on Zacks.com





Chemed's (CHE) Earnings and Revenues Beat Estimates in Q1
Chemed Corp.'s (CHE) first-quarter 2017 adjusted earnings per share (EPS) (considering stock-based compensation expense and related tax benefit as a regular one) were $1.92, as compared to the year-ago adjusted EPS figure of $1.52, up 26.3% year over year.

Apr. 27, 2017 at 9:03 a.m. ET
on Zacks.com





Heska's (HSKA) CEO Kevin Wilson on Q1 2017 Results - Earnings Call Transcript
Heska's (HSKA) CEO Kevin Wilson on Q1 2017 Results - Earnings Call Transcript

May. 2, 2017 at 4:03 p.m. ET
on Seeking Alpha





Here's Why Heska Corporation Is Dropping Today


May. 2, 2017 at 12:33 p.m. ET
on Motley Fool





Notable earnings before Tuesday’s open
Notable earnings before Tuesday’s open

May. 1, 2017 at 5:30 p.m. ET
on Seeking Alpha





Sarepta (SRPT) Q1 Loss Narrows, Exondys 51 Sales Pick Up
Sarepta Therapeutics, Inc. (SRPT) reported narrower-than-expected loss in the first quarter of 2017. Meanwhile, the biotech company increased its 2017 sales outlook for Exondys 51 as patient and physician interest for the drug increased

Apr. 28, 2017 at 10:43 a.m. ET
on Zacks.com





Acorda (ACOR) Q1 Loss Wider Than Expected, Revenues Miss 
Acorda Therapeutics, Inc. (ACOR) reported loss of 25 cents per share in the first quarter of 2017 (including the impact of stock-based compensation expenses), wider than the Zacks Consensus Estimate of a loss of 16 cents. 

Apr. 28, 2017 at 10:29 a.m. ET
on Zacks.com





AstraZeneca (AZN) Q1 Earnings Beat, Revenues Meet Estimates
AstraZeneca PLC (AZN) reported first-quarter 2017 core earnings of 99 cents per American Depositary Share, which comfortably beat the Zacks Consensus Estimate of 38 cents. 

Apr. 28, 2017 at 10:31 a.m. ET
on Zacks.com





Align Technology (ALGN) Beats on Q1 Earnings and Revenues
Align Technology Inc. (ALGN) reported adjusted earnings per share (EPS) of 85 cents in the first quarter of 2017, up 70% from 50 cents posted in the year-ago quarter. 

Apr. 28, 2017 at 9:31 a.m. ET
on Zacks.com





Seattle Genetics (SGEN) Q1 Loss Widens, Sales Top Estimates
Seattle Genetics, Inc. (SGEN) reported a loss of 42 cents per share for the first quarter of 2017, wider than the Zacks Consensus Estimate of a loss of 41 cents and the year-ago loss of 15 cents per share.

Apr. 28, 2017 at 9:57 a.m. ET
on Zacks.com









Heska to Present at Canaccord Genuity 37th Annual Growth Conference on August 10
Heska to Present at Canaccord Genuity 37th Annual Growth Conference on August 10

Jul. 20, 2017 at 4:05 p.m. ET
on PR Newswire - PRF





Heska Schedules Second Quarter 2017 Financial Results Conference Call for July 31, 2017
Heska Schedules Second Quarter 2017 Financial Results Conference Call for July 31, 2017

Jul. 11, 2017 at 8:00 a.m. ET
on PR Newswire - PRF





Scott Humphrey Joins Heska's Board of Directors
Scott Humphrey Joins Heska's Board of Directors

Jun. 13, 2017 at 9:00 a.m. ET
on PR Newswire - PRF





Investor Network: Heska Corporation to Host Earnings Call
Investor Network: Heska Corporation to Host Earnings Call

May. 2, 2017 at 8:05 a.m. ET
on ACCESSWIRE





Heska Reports First Quarter Results
Heska Reports First Quarter Results

May. 2, 2017 at 8:00 a.m. ET
on PR Newswire - PRF





Heska To Present at Four Upcoming Conferences
Heska To Present at Four Upcoming Conferences

Apr. 27, 2017 at 8:00 a.m. ET
on PR Newswire - PRF





Reminder: Heska Annual Meeting of Stockholders on May 1, 2017
Reminder: Heska Annual Meeting of Stockholders on May 1, 2017

Apr. 25, 2017 at 5:20 p.m. ET
on PR Newswire - PRF





Heska Schedules First Quarter 2017 Financial Results Conference Call for May 2, 2017


Apr. 13, 2017 at 8:00 a.m. ET
on PR Newswire - PRF





Heska Schedules Annual Meeting of Stockholders for May 1, 2017


Apr. 12, 2017 at 8:00 a.m. ET
on PR Newswire - PRF





Gartner Set to Join S&P 500; Dun & Bradstreet, Wintrust Financial and INC Research to Join S&P MidCap 400; Heska to Join S&P SmallCap 600


Mar. 29, 2017 at 6:21 p.m. ET
on PR Newswire - PRF





Post Earnings Coverage as VWR Corp. Q4 2016 Results Outperformed Projections


Mar. 14, 2017 at 8:23 a.m. ET
on ACCESSWIRE





Heska Reports Record Quarter and Annual Results


Feb. 28, 2017 at 8:00 a.m. ET
on PR Newswire - PRF





Heska Schedules Fourth Quarter and Year-End 2016 Financial Results Conference Call for February 28, 2017


Jan. 31, 2017 at 4:27 p.m. ET
on PR Newswire - PRF





Heska to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum on November 17


Nov. 3, 2016 at 8:00 a.m. ET
on PR Newswire - PRF





Heska Reports Record Third Quarter Results


Nov. 1, 2016 at 8:00 a.m. ET
on PR Newswire - PRF





Heska Schedules Third Quarter 2016 Earnings Release and Conference Call for November 1, 2016


Oct. 19, 2016 at 8:00 a.m. ET
on PR Newswire - PRF





Heska Announces Executive Promotions to Further Growth Initiatives


Sep. 29, 2016 at 5:35 p.m. ET
on PR Newswire - PRF





Heska to Present at CL King's 14th Annual Best Ideas Conference 2016 on September 13


Sep. 6, 2016 at 9:00 a.m. ET
on PR Newswire - PRF





Heska to Present at CL King's 14th Annual Best Ideas Conference 2016 on September 13


Sep. 6, 2016 at 9:00 a.m. ET
on PR Newswire - PRF





Heska to Present at Canaccord Genuity 36th Annual Growth Conference on August 10, 2016


Aug. 4, 2016 at 12:00 p.m. ET
on PR Newswire - PRF











Heska Corp.


            
            Heska Corp. engages in the research, development and manufacture of veterinary products. The company operates through two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals & Products. The Core Companion Animal Health segment supplies blood testing instruments, digital imaging software, heartworm diagnostic tests and preventive products, allergy immunotherapy products, and allergy testing. The Other Vaccines, Pharmaceuticals and Products segment develops and distributes vaccines and pharmaceutical products. Its solutions include, dri-chem 4000, 7000, hematrue, element ht5, element i and solo step heartworm. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

            
            (See Full Profile)


  




Analyst Ratings



Sell
Under
Hold
Over
Buy

Number of Ratings 7
Full Ratings 





Benzinga's Top Initiations


Nov. 29, 2016 at 9:22 a.m. ET
on Benzinga.com





Canaccord Fireside Chat Takeaways For Abaxis, Heska


Aug. 16, 2016 at 4:00 p.m. ET
on Benzinga.com





Benzinga's Top Initiations


Apr. 1, 2016 at 9:33 a.m. ET
on Benzinga.com





 


Competitors




Name
Chg %
Market Cap




Abaxis Inc.
-1.24%
$1.16B


IDEXX Laboratories Inc.
-0.40%
$14.68B


Immucell Corp.
-0.15%
$31.8M


VCA Inc.
0.01%
$7.51B


Novartis AG ADR
-0.50%
$221.79B




Competitor Data Provided By


   






   



























Partner Content























Trending Tickers
Powered by 





APRN

0.46%








GNCA

2.02%








DVAX

0.52%








WBMD

-0.11%








PETS

3.98%
























Advanced Search







Stocks



Columns


Authors


Topics







No results found





























Video Center










Learn more.Storyful, a division of News Corp, which owns MarketWatch, is a leading social media services company headquartered in Dublin, Ireland. Storyful combines world class journalism with industry-leading technology to discover, verify and acquire original content and provide the on-the-ground sources news and media organizations need to tell the stories that matter to their audience.












Heska Corp 2538 SE 43rd St Pleasant Hill, IA Animal Health Products - MapQuest







































































































    Heska Corp
  

2538 SE 43rd St

Pleasant Hill
IA
50327




 Reviews



(515) 263-9581

        Menu & Reservations
      



            Make Reservations 




            Order Online
          

            Tickets
          




          Tickets
        


        See Availability
      





      Nearby
    


      Directions
    


    {{::location.tagLine.value.text}}
  



Sponsored Topics








































See a problem?
Let us know!






















Legal






Help






























Page not found - TheStreet

















 

 




















Action Alerts PLUS

Access AAPJim Cramer's Best Stocks for 2017Charitable Trust PortfolioMost Recent Trade Alert25 Investing Rules10 Trading Commandments

Real Money

Access RM25 Rules of InvestingJim Cramer's Best Stocks for 201710 CommandmentsStressed Out StocksCramer's Blog

Cramer
Mad Money
ETFs
Futures
Markets
Much More

BanksBiotechRetailTechPersonal FinanceRetirementFinancial Advisor CenterHow to SpendOptionsFixed IncomeVideo










Privacy Policy|Terms of Use© 1996- TheStreet Inc. All rights reserved
















                                DJIA
                            







                                NASDAQ
                            







                                S&P 500
                            






Market Data updated






Sign In




Your Membership(s)








Your Account





Account Preferences


Alerts


Newsletters







Subscribe





Logout



Subscribe

Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Action Alerts PLUS
Action Alerts OPTIONS
Daily Swing Trade
Income Seeker
Quant Ratings
Real Money
Real Money Pro
Stocks Under $10
Top Stocks
Trifecta Stocks
Real Money Pro Portfolio
Chairman's Club
Compare All 
Chatter on the Street




































 
















Page not found

        Sorry, the page you're looking for is not available.
    
    You might want to try:
    

Our homepage


Our most popular stories






























 


©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.




Compare Brokers



 







 







 







 







 







 












Heska Corporation HSKA Profile-Financials-Revenues-Growth-Market-Description                       Please wait while the search results are loading...     Plunkett Research,® Ltd.Our Market Research = Your Smart Decisions  What are you looking for?    Information Marketing & Research PROS   Information for Students & Professors   Subscribers Log In     Home >  Industries  >    > Heska Corporation     Plunkett Research Online: Heska Corporation    HESKA CORPORATION (HSKA) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOTHeska Corporation focuses on the discovery, development, manufacture, marketing and support of animal health care products. The firm is divided into two segments: core companion animal health and other vaccines, pharmaceuticals and products.  Core companion animal health includes, primarily for cani..... � HESKA CORPORATION  �  Ticker: HSKAExchange: NASParent Company: Employees: Fiscal Year Ends in  Phone: 970 493-7272Fax: 970 619-3003Address: 3760 Rocky Mountain Ave.Loveland, CO 80538 United States MapTypes Of Business Industry Ranks  Total Revenue�Market Cap�Employee Count �Net Income �Revenue 3Y Growth �Income 3Y Growth �Return on Assets (%) �Return on Equity (%) �Return on Invested Capital (%) � Industry NAICS code:   Refreshing... Contacts Excel TextDescription Kevin WilsonCEO/Chief Accounting Officer/Director/PresidentCarol WrennDirector See More Heska Corporation focuses on the discovery, development, manufacture, marketing and support of animal health care products. The firm is divided into two segments: core companion animal health and other vaccines, pharmaceuticals and products. Core companion animal health includes, primarily for cani.....See More See More  Financials $USD, In whole numbers 2016201520142013201220112010SalesProfitsBrands, Divisions and AffiliatesTop Salaries  SalaryBonusOther ThoughtsCorporate Culture    Javascript is disabled.    Request Free Trial Subscriptions Plans & Pricing500 Industries Analyzed for Market Size, Profits and Forecasts25,000 Companies Profiled, Ranked100,000 Industry Statistics150,000 Industry Executives Profiled1,000,000 Words of Trends Analysis Printed Almanacs and Ebooks Custom Research ProjectsA REPRESENTATIVE LIST OF ORGANIZATIONS THAT HAVE USED OUR RESEARCH PRODUCTS:         Take a TourHow to Use Plunkett Research Online-8 MinutesPlunkett Online AccessPlunkett Research BooksContactPhone: 713.932.0000Alternate Phone: 713.961.3282Fax: 713.932.7080E-Mail UsAsk a Product QuestionMedia Interviews, Get a SpeakerCustom ResearchInternational Distributors ListNews & RSSTestimonials  Your tool is very comprehensive and immensely useful. The vertical marketing tool is very helpful, for it assists us in that venue, as well as targeting customers’ competition for new sales…The comprehensive material is absolutely fabulous. I am very impressed, I have to say! Tammy Dalton, National Account Manager, MCI, Tammy Dalton  We are especially trying to push Plunkett since all of our students have to do so much industry research and your interface is so easy to use.  St. John’s College, Library Services  I’m amazed at how much information is available and the various ways to access it. This will be a major resource for our serious job seekers.  Penn State University, Career Services  I really appreciate the depth you were able to get to so quickly (for our project). The team has looked through the material and are very happy with the data you pulled together.  Marketing Manager, Hilton Worldwide  Plunkett Research Online is an excellent resource…the database contains a wealth of useful data on sectors and companies, which is easy to search and well presented.   Help and advice on how to conduct, export and save searches is available at all stages. Penny Crossland, Editor, VIP Magazine  The more I get into the database, the happier I am that we’ll have it–REALLY happy!!!  Between the quality and affordability of your product, its appeal to and value for our users, and the inestimably ethical and loyalty-guaranteeing conduct of your business, I will always have more than sufficient praises to sing for Plunkett Research. Michael Oppenheim, Collections & Reference Services, UCLA  Plunkett Research Online provides a great ‘one stop shop’ for us to quickly come up to speed on major industries. It provides us with an overall analysis of the market, key statistics, and overviews of the major players in the industry in an online service that is fast, easy to navigate, and reliable. Wendy Stotts, Manager, Carlson Companies-Information Center  We are especially trying to push Plunkett’s since all of our students have to do so much industry research and your interface is so easy to use. Gary White, Business Materials Selector, Penn State University     Sign up for Free Research Reports   Subscribe                                 
     HSKA | Stocks Profile for Heska Corp                                      
               Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.       Market Data & B2B Solutions       Report a Bug    Give Feedback   Market:  Market:         US       Canada       UK       Australia            Financial Technology & Market Data    Market Data Feeds   OnDemand Web APIs   Website Solutions     Barchart Trader   Mobile Solutions   ISV Solutions     Content Overview   Enterprise Data Management (EDM)   Agribusiness Technology Solutions                                                      No Matching Results   Advanced search      or   Select a Commodity  Wheat Corn Soybeans Soybean Meal Soybean Oil Oats Rough Rice Hard Red Wheat Spring Wheat Canola   U.S. Dollar Index British Pound Canadian Dollar Japanese Yen Swiss Franc Euro FX Australian Dollar Mexican Peso New Zealand Dollar South African Rand Brazilian Real Russian Ruble   Crude Oil WTI ULSD NY Harbor Gasoline RBOB Natural Gas Crude Oil Brent Ethanol   T-Bond Ultra T-Bond 10 Year T-Note 5 Year T-Note 2 Year T-Note 30 Day Fed Funds Eurodollar   S&P 500 E-Mini Nasdaq 100 E-Mini Dow Indu E-Mini Russell 2000 E-Mini S&P Midcap E-Mini S&P 500 VIX S&P GSCI   Live Cattle Feeder Cattle Lean Hogs Class III Milk   Gold Silver High Grade Copper Platinum Palladium   Cotton #2 Orange Juice Coffee Sugar #11 Cocoa Lumber   ICE Crude Oil Brent ICE Crude Oil WTI ICE Gas Oil ICE Natural Gas ICE RBOB Blendstock ICE Heating Oil   Euro Bund Euro Bobl Euro Schatz Euro Buxl Euro OAT Long-Term Euro BTP Long-Term Eurex Conf Long-Term Euro Bono Long-Term 10-Year Long Gilt 3-Month EuriBor 3-Month Sterling 3-Month Euroswiss   Rapeseed Feed Wheat Milling Wheat Corn   Euro Stoxx 50 Index FTSE 100 Index DAX Index Swiss Market Index CAC 40 Index AEX Index BEL 20 PSI 20 IBEX 35-Mini OMX Swedish Index VSTOXX Mini   Steel Scrap Steel Rebar   Cocoa #7 Coffee Robusta 10-T Sugar White #5                Stocks   Stocks        Market Pulse   Market Overview   Market Momentum   Market Performance   Top 100 Stocks   Today's Price Surprises   New Highs & Lows   Economic Overview   Earnings Within 7 Days   Earnings & Dividends   Stock Screener     Performance Leaders   Percent Change   Price Change   Range Change   Gap Up & Gap Down   Five Day Gainers         Most Active   Volume Leaders   Price Volume Leaders   Volume Advances   Trading Liquidity     Indices   Major Indices   S&P Indices   S&P Sectors   DOW Indices   Nasdaq Index   Russell Indices   Volatility Indices   Commodities Indices   US Sectors Indices         Trading Signals   New Recommendations   Top Stocks to Own   Top Signal Strength   Top Signal Direction   Stock Signal Upgrades     Sectors   Major Market Sectors   Industry Rankings   Industry Performance            Futures   Futures        Market Pulse   Market Overview   Long Term Trends   Today's Price Surprises   Highs & Lows   Futures Market Map   Performance Leaders   Most Active Futures   Prices by Exchange   Commitment of Traders     Commodity Groupings   Major Commodities   Currencies   Energies   Financials   Grains   Indices   Meats   Metals   Softs         Trading Signals   New Recommendations     Resources   Contract Specifications   Futures Expirations   First Notice Dates   Options Expirations         European Futures   Long Term Trends   Today's Price Surprises   Highs & Lows   Futures Market Map   Performance Leaders   Most Active Futures     European Groupings   Major Commodities   Energies   Financials   Grains   Indices   Metals   Softs            Forex   Forex        Market Pulse   Market Overview   Long Term Trends   Today's Price Surprises   Highs & Lows   Forex Market Map   Performance Leaders         Currency Groupings   Major Cross Rates   Australian Dollar   British Pound   Canadian Dollar   Euro FX   Japanese Yen   Swiss Franc   US Dollar   Metals Rates   All Forex Markets         Trading Signals   New Recommendations     Resources   Currency Converter             Options   Options        Market Pulse   Market Overview   Unusual Options Activity   Most Active Options   Highest Implied Volatility   %Change in Volatility   Change in Open Interest   Volume Leaders         Advanced Groupings   Covered Calls   Naked Puts   Bull Call Spreads   Bear Call Spreads   Bear Put Spreads   Bull Put Spreads         Optionable Stocks   Upcoming Earnings   Stocks by Sector            ETFs & Funds   ETFs & Funds        Market Pulse   Market Overview   Major ETFs   ETFs by Asset Class   Top 100 ETFs   Today's Price Surprises   New Highs & Lows   ETFs Screener     Performance Leaders   Percent Change   Price Change   Range Change   Gap Up & Gap Down   Five Day Gainers         Most Active   Volume Leaders   Price Volume Leaders   Volume Advances     Trading Signals   New Recommendations   Top ETFs to Own   Top Signal Strength   Top Signal Direction   ETFs Signal Upgrades         Mutual Funds   Today's Price Surprises   New Highs & Lows   Performance   Price Change   Funds Screener            News   News        Market Pulse   News Overview   Top Stories   Forex News   Options News     Futures Commentary   All Sectors   Currencies   Energies   Financials   Grains   Indices   Meats   Metals   Softs         News by Sector   Aerospace   Agriculture   Business Services   Construction   Consumer Products   Corporate   Economy   Energy & Oil   Finance and Banking   Industrial Products   Leisure & Recreation   Media   Medical   Retail Sales   Technology & Computers   Transportation   Utilities         Barchart Exclusive   Van Meerten Stock Picks   Chart of the Day   Barchart Morning Call     Featured Sources   Zacks News   Brugler Ag Report            My Barchart   My Barchart   My Barchart        Tools   My Barchart   Watchlist   Portfolio   Portfolio Summary   Alerts         Manage Tools   Organize Watchlists   Organize Portfolios   Organize Screeners   Custom Views   Chart Templates     Account   My Profile   Site Preferences         Subscriptions   End-of-Day Watchlists   End-of-Day Portfolios   End-of-Day Reports   Barchart Newsletters   Barchart Premier           Premium Services        Barchart Premier    Access a cleaner, faster browsing experience of Barchart.com with tools and services exclusive to Premier Members.   Learn More      Trends in Futures    Learn how to analyze long term trends with Trader and Barchart's Chief Market Strategist, Gary Kamen.   Learn More      Barchart Trader    Trade from your desktop, tablet or phone with our real-time trading software.   Learn More      Futures Trading Education    Launch your own "Greatest Business on Earth" by following seasoned trader, Jim Prince, as he breaks down best ways to trade commodities.   Learn More                                          Menu      quotes   Overview   Performance Report     charts   Interactive Chart   Technical Chart      

                -->
    



  technicals   Technical Analysis   Trader's Cheat Sheet   Barchart Opinion   Trading Strategies   Price History     company   News   Profile   SEC Filings   Competitors   Stock Comparison     analysts   Earnings Estimates   Analyst Ratings     financials   Income Statement   Cash Flow   Balance Sheet         

                -->
    



        

                -->
    


        Heska Corp (HSKA)     [[ item.lastPrice ]]  [[ item.priceChange ]]  ([[ item.percentChange ]])  [[ item.tradeTime ]]  [NASDAQ]    [[ item.bidPrice ]] x [[ item.bidSize ]]  [[ item.askPrice ]] x [[ item.askSize ]]    [[ session ]]  by (BATS)    [[ item.lastPrice ]]  [[ item.priceChange ]]  ([[ item.percentChange ]])  [[ item.tradeTime ]] [NASDAQ]    [[ item.bidPrice ]]  x [[ item.bidSize ]]  [[ item.askPrice ]]  x [[ item.askSize ]]    [[ session ]] [[ item.lastPriceExt ]]  [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]])  [[ item.tradeTimeExt ]]     Profile for [[ item.sessionDateDisplayLong ]]      Go To:     Overview     Performance Report     Interactive Chart     Technical Chart     Technical Analysis     Trader's Cheat Sheet     Barchart Opinion     Trading Strategies     Price History     News     Profile     SEC Filings     Competitors     Stock Comparison     Earnings Estimates     Analyst Ratings     Income Statement     Cash Flow     Balance Sheet          Set Alerts    Watchlist       Company Info   Heska Corp 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 USA   www.heska.com P: 970-493-7272 F: 970-619-3003    Sectors:   SIC-2836 Biological Products, (No Disgnostic Substanc   Indices S&P 600   Medical - Biomedical     Description: Heska Corporation is focused on the discovery, development and marketing ofcompanion animal health products. In addition to manufacturing certain ofcompanion animal products, the company's primary manufacturing subsidiary, Diamond Animal Health, Inc., also manufactures animal health vaccine products which are marketed and distributed by third parties. In addition to manufacturing veterinary allergy products for marketing and sale by the company, subsidiaries, Center Laboratories, Inc. and CMG-Heska Allergy Products S.A., also manufacture and sell human allergy products.    Key Statistics  Overview:     Market Capitalization, $K     713,210       Shares Outstanding, K     7,120       Annual Sales, $     130,080 K       Annual Net Income, $     10,510 K       36-Month Beta     0.81       % of Insider Shareholders     14.70%       % of Institutional Shareholders     81.82%     Growth:     1-Year Total Return     136.47%       3-Year Total Return     791.99%       5-Year Total Return     886.90%       5-Year Revenue Growth     85.64%       5-Year Earnings Growth     257.50%       5-Year Dividend Growth     0.00%     Per-Share Information:     Most Recent Earnings     0.32 on 05/02/17       Next Earnings Date     07/31/17       Earnings Per Share ttm     1.87       EPS Growth vs. Prev Qtr     32.61%       EPS Growth vs. Prev Year     258.82%       Annual Dividend Rate, $     0.00       Annual Dividend Yield     0.00%       Most Recent Dividend     0.10 on 09/26/12           Dividend Payout Ratio     0.00       Most Recent Split     1-10 on 12/30/10             HSKA Ratios     Ratio     Price/Earnings ttm 54.23   Price/Earnings forward 52.45   Price/Earnings to Growth 3.16   Return on Equity % 12.08   Return on Assets % 10.96   Profit Margin % 8.08   Debt/Equity 0.00   Price/Sales 5.55   Price/Cash Flow 46.18   Price/Book 7.74   Book Value/Share 13.09   Interest Coverage 0.00        

                -->
    



           Log In or Sign Up    Log Out      Market:  Market:         US       Canada       UK       Australia       HOME    Stocks   Market Pulse  Market Overview Market Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener    Performance Leaders  Percent Change Price Change Range Change Gap Up & Gap Down Five Day Gainers    Most Active  Volume Leaders Price Volume Leaders Volume Advances Trading Liquidity    Indices  Major Indices S&P Indices S&P Sectors DOW Indices Nasdaq Index Russell Indices Volatility Indices Commodities Indices US Sectors Indices    Trading Signals  New Recommendations Top Stocks to Own Top Signal Strength Top Signal Direction Stock Signal Upgrades    Sectors  Major Market Sectors Industry Rankings Industry Performance      Futures   Market Pulse  Market Overview Long Term Trends Today's Price Surprises Highs & Lows Futures Market Map Performance Leaders Most Active Futures Prices by Exchange Commitment of Traders    Commodity Groupings  Major Commodities Currencies Energies Financials Grains Indices Meats Metals Softs    Trading Signals  New Recommendations    Resources  Contract Specifications Futures Expirations First Notice Dates Options Expirations    European Futures  Long Term Trends Today's Price Surprises Highs & Lows Futures Market Map Performance Leaders Most Active Futures    European Groupings  Major Commodities Energies Financials Grains Indices Metals Softs      Forex   Market Pulse  Market Overview Long Term Trends Today's Price Surprises Highs & Lows Forex Market Map Performance Leaders    Currency Groupings  Major Cross Rates Australian Dollar British Pound Canadian Dollar Euro FX Japanese Yen Swiss Franc US Dollar Metals Rates All Forex Markets    Trading Signals  New Recommendations    Resources  Currency Converter       Options   Market Pulse  Market Overview Unusual Options Activity Most Active Options Highest Implied Volatility %Change in Volatility Change in Open Interest Volume Leaders    Advanced Groupings  Covered Calls Naked Puts Bull Call Spreads Bear Call Spreads Bear Put Spreads Bull Put Spreads    Optionable Stocks  Upcoming Earnings Stocks by Sector      ETFs & Funds   Market Pulse  Market Overview Major ETFs ETFs by Asset Class Top 100 ETFs Today's Price Surprises New Highs & Lows ETFs Screener    Performance Leaders  Percent Change Price Change Range Change Gap Up & Gap Down Five Day Gainers    Most Active  Volume Leaders Price Volume Leaders Volume Advances    Trading Signals  New Recommendations Top ETFs to Own Top Signal Strength Top Signal Direction ETFs Signal Upgrades    Mutual Funds  Today's Price Surprises New Highs & Lows Performance Price Change Funds Screener      News   Market Pulse  News Overview Top Stories Forex News Options News    Futures Commentary  All Sectors Currencies Energies Financials Grains Indices Meats Metals Softs    News by Sector  Aerospace Agriculture Business Services Construction Consumer Products Corporate Economy Energy & Oil Finance and Banking Industrial Products Leisure & Recreation Media Medical Retail Sales Technology & Computers Transportation Utilities    Barchart Exclusive  Van Meerten Stock Picks Chart of the Day Barchart Morning Call    Featured Sources  Zacks News Brugler Ag Report      My Barchart   Tools  My Barchart Watchlist Portfolio Portfolio Summary Alerts    Manage Tools  Organize Watchlists Organize Portfolios Organize Screeners Custom Views Chart Templates    Account  My Profile Site Preferences    Subscriptions  End-of-Day Watchlists End-of-Day Portfolios End-of-Day Reports Barchart Newsletters Barchart Premier      B2B SOLUTIONS   Market Data Feeds OnDemand Web APIs Website Solutions Barchart Trader Mobile Solutions ISV Solutions Enterprise Data Management (EDM) Agribusiness Technology Solutions        Report a Bug      Give Feedback          Profile        The Profile page gives you general information about a symbol, whether it's about the company or the contract. Barchart shows different data on the Profile page, depending on the symbol's asset type. Stocks A stock Profile page contains general information about the stock, such as Ticker Symbol, Exchange traded on, Company Contact Address/Phone, CEO/President, and Company Description. It also includes links to the Industry, Sector, and Index in which the stock belongs: the SIC or the Standard Industrial Classification code, industry groups, and major-market indices including the three Dow Jones indices and their composite, the Nasdaq 100, and the S&P 500, 100 and 400. For stocks, all fundamental information is provided by Zachs Investment Research. Growth Table The 1-3- and 5-Year Returns are adjusted for dividends and splits.  Example: AAPL traded on 06/04/2012 at 72.81. On 06/04/2017, AAPL was trading at 155.45 and the 5-Year Return was reported as 113.50%. 1.1350 * 72.81 = 82.64 + 72.81 = 155.45 which is the current price. ETFs An ETF Profile page also shows general information about the fund, but also adds information such as a link to the Fund Family. the Underlying Index. Inception Date, First Trade Date, and Leverage. Investment Information Table The YTD, 1-3- and 5-Year Returns are adjusted for dividends and splits.  Futures A Profile for a commodities contract contains the Contract Specifications. Specifications include:  Symbol - the root symbol for the commodity. Name - the commodity description Exchange - the exchange on which the commodity is traded. Months - A specific month in which delivery may take place under the terms of a futures contract. Commodity exchanges typically refer to months using one letter:  January = F February = G March = H April = J May = K June = M July = N August = Q September = U October = V November = X December = Z   Size - (sometimes referred to as Trading Unit) refers to the unit of measure in which the contract is traded. Common abbreviations you'll see include:  bu = bushel lbs = pounds cwt = hundred weight bbl = barrel gal = gallon mm btu = million British thermal units bd = board foot oz = ounce M = million ct = cents pt = point   Tick Size - the smallest allowable increment of price movement for a contract. Daily Limit - the maximum gain or loss that the commodity is permitted to reach for a given trading session. Trading Hours - the days and hours in which the commodity is traded. Last Trading Day - the day in which trading terminates for this commodity for each Trading Month. Value of one futures unit - a measure of one basis point change in the futures price. Value of one options unit - a measure of one basis point change in the options price. CRB Yearbook Description - for commodities, the previous year's CRB Yearbook article will appear. Information includes a description/outlook for the commodity, prices, supply, demand, and trade statistics.                                  Add Data Columns to this Table Learn about our Custom Views   Want to use this as  your default charts setting? Learn about our Custom Templates   Switch the Market flag above for targeted data. Open the menu and switch the  Market flag for targeted data.    
























Heska Monitor Accessories










































Attention: Either you have JavaScript disabled or your browser does not support JavaScript. To work properly, this site requires that you  enable JavaScript.













            1-800-225-7911
             | 
Help













                Choose Your Support
            

                Online Support
            
Questions about your order or about the website? 

                Choose from the following:
            





Supported Browsers








                        Chat Online Live
                    







                    Call us at 1-877-816-2871

                







                        Send us an email
                    








                        Read the FAQ page
                    








                        Watch online tutorials
                    



                Local Support
            
Questions about a product or a service you see on our site? 

                Choose from the following:
            






Contact your sales representative


Contact your local branch









                Sign In
            























Heska Monitor Accessories
HESKA CORP

See My Price















Available Products










Description


Patterson
Item #


Mfg
Item #






Price


Status


Qty
















Airway Adapters
HESKA CORP




















                        Straight- 8/pkg
                    

N/A





07-854-0336


CAT 7040








See My Price



                            N/A
                        





































Patient Cables
HESKA CORP




















                        Temperature Breakout/Oximeter Interface Cable- 7' for 4700 Monitor
                    

N/A





07-835-9412


CAT 6082








See My Price



                            N/A
                        





































Sensors/Probes
HESKA CORP




















                        Exotic Reflectance Sensor
                    

N/A





07-856-8508


CAT 4054








See My Price



                            N/A
                        


































                        Respiration Sensor with 2 Airway Adapters-  for 4404 Monitor
                    

N/A





07-835-8974


CAT 4076








See My Price



                            N/A
                        


































                        Standard Reflectance Sensor
                    

N/A





07-836-2346


CAT 4050








See My Price



                            N/A
                        


































                        Universal C Sensor
                    

N/A





07-836-3106


CAT 4065








See My Price



                            N/A
                        





































Temperature Cables/Probes
HESKA CORP




















                        Cable and Probe- for Vet/Ox 4404
                    

N/A





07-843-0699


CAT 6076








See My Price



                            N/A
                        



















































Close





















                Legend
            







Additional Information



DEA



Hazmat - Chargeable



Ice



List 1



MSDS



My eCustom Catalog



Hazmat - No Charge



Pedigree



Prescription



Promotion



This item is on your Formulary list.












Sign In




                            Sign In
                        





Request Patterson Veterinary Account


Create Online Account








                    New Arrivals
                



















Lactated Ringer's Injection - 1000 ml - 12/Case


                                    07-892-7200
                                    ASPEN VET
                                    Lactated Ringer's Injection is a sterile, non-pyrogenic solution intended for fluid and electrolyte replenishment in single dose containers. 


See My Price















Latex Powder Free Sterile Surgical Gloves - 7.5 - 25 Pairs/Box


                                    07-892-9622
                                    ASPEN VET
                                    Natural rubber latex surgical gloves, Sterile, Powder free, Cuffed, Single use.


See My Price
















Purina® Pro Plan® Veterinary Diets UR Savory Selects Urinary™ St/Ox™ Feline Formula - 5.5 oz Cans - Variety Pack (12 Cans Turkey & Giblets, 12 Cans Salmon)


                                    07-893-1010
                                    NESTLE PURINA PETCARE
                                    5.5 oz Cans - Variety Pack (12 Cans Turkey & Giblets, 12 Cans Salmon)



See My Price







































Home Page - Heska






























































 Log in























Investor RelationsOverview
Stock Information
SEC Filings
News Releases
Management Team
Board of Directors
Most Recent Presentation
Corporate Governance
Annual Reports
Information Request
Investor Contact Hayden IR
15879 N. 80th Street
2nd Floor
Scottsdale, AZ 85260
Brett Maas
brett@haydenir.com
(646) 536-7331



Investor Relations
Heska Corporation (NASDAQ: HSKA) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and financial documents. Heska Corporation is traded on the NASDAQ under the ticker symbol HSKA.
Overview
Heska Corporation sells advanced veterinary diagnostic and other specialty veterinary products. Heska’s state-of-the-art offerings to its customers include blood testing instruments and supplies, digital imaging products, software and services, and single use products and services such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing. The Company’s core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians.

View Our Presentation








HSKANASDAQVOLUMECHANGE


  

Diagnostics/Treatment
Digital Imaging
Allergy Testing & Treatment
Customer Support
Company
Privacy Policy
Terms and Conditions
Conditions of Sale/Rental








Optimization WordPress Plugins & Solutions by W3 EDGE 











